Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2022 Oct 14;18(10):e1010448. doi: 10.1371/journal.pgen.1010448

Nascent polypeptide-Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling

Analyne M Schroeder 1,*, Tanja Nielsen 1, Michaela Lynott 1, Georg Vogler 1, Alexandre R Colas 1, Rolf Bodmer 1,*
Editor: Pablo Wappner2
PMCID: PMC9604979  PMID: 36240221

Abstract

Establishing a catalog of Congenital Heart Disease (CHD) genes and identifying functional networks would improve our understanding of its oligogenic underpinnings. Our studies identified protein biogenesis cofactors Nascent polypeptide-Associated Complex (NAC) and Signal-Recognition-Particle (SRP) as disease candidates and novel regulators of cardiac differentiation and morphogenesis. Knockdown (KD) of the alpha- (Nacα) or beta-subunit (bicaudal, bic) of NAC in the developing Drosophila heart disrupted cardiac developmental remodeling resulting in a fly with no heart. Heart loss was rescued by combined KD of Nacα with the posterior patterning Hox gene Abd-B. Consistent with a central role for this interaction in cardiogenesis, KD of Nacα in cardiac progenitors derived from human iPSCs impaired cardiac differentiation while co-KD with human HOXC12 and HOXD12 rescued this phenotype. Our data suggest that Nacα KD preprograms cardioblasts in the embryo for abortive remodeling later during metamorphosis, as Nacα KD during translation-intensive larval growth or pupal remodeling only causes moderate heart defects. KD of SRP subunits in the developing fly heart produced phenotypes that targeted specific segments and cell types, again suggesting cardiac-specific and spatially regulated activities. Together, we demonstrated directed function for NAC and SRP in heart development, and that regulation of NAC function depends on Hox genes.

Author summary

Identifying novel genes involved in cardiac development could help patients with Congenital Heart Disease through improved understanding of the developmental missteps, more precise patient diagnosis, and invention of targeted medical interventions. We identified protein biogenesis cofactors Nascent polypeptide Associated Complex (NAC) and Signal Recognition Peptide (SRP) to be involved in cardiac specific roles during development. Disruption of NAC and SRP subunits led to distinct and cell targeted disruptions in the heart, which would be unexpected if NAC and SRP merely had generic cellular function. Specifically, in flies, knockdown (KD) of the alpha- subunit of NAC, Nacα, led to an adult fly with no heart that could be rescued by co-KD with the posterior patterning Hox gene Abd-B, indicating a critical developmentally relevant genetic interaction, and not merely a generic protein biogenesis defect. This interaction was recapitulated in human Cardiac Progenitors, whereby human NACA KD redirected progenitor differentiation away from cardiomyocyte and toward fibroblast fates, which was rescued by concomitant Hox gene KD. Lastly, Nacα activity was required at specific times during development, and depending on when Nacα was knocked down, the resulting adult heart could be mildly or severely malformed. Thus, the work presents a new class of genes involved in protein biogenesis that display tissue- and temporal-specific activities that are crucial for proper heart development.

Introduction

Congenital Heart Disease (CHD) is characterized by structural malformations of the heart present at birth caused by deviations from the normal course of cardiogenesis [1]. Genetics is a critical driver of CHD [2, 3]. Chromosomal anomalies as well as variants in genes involved in heart development have been identified in CHD patients [4]. These genetic features and disease presentations are heritable and cluster in families [5, 6]. Identifying the genes associated with disease helps piece together genetic networks that could uncover mechanisms underlying pathogenesis. Approximately 400 genes have been implicated in CHD [2], some that cluster within defined pathways, which permits a genetic diagnosis for approximately 20% of CHD patients. However, this leaves the vast majority of CHD cases with unknown genetic origins [3]. Therefore, expansion of the genetic data pertinent to CHD, such as functional analysis of genes with variants of uncertain significance (VUS), would advance our understanding of the disease and may offer, in the future, a diagnosis and targeted treatment for CHD patients. A better understanding of additional genetic risk factors and patient-specific combinations of such factors is aided by identification of candidate disease genes through patient-specific genomics, such as whole genome sequencing (WGS), followed by their evaluation in cardiac developmental platforms and assays from various genetic model systems [7, 8]. These validation efforts can accelerate candidate gene identification and focus on new potentially pathogenic genes, including genes located within larger genomic anomalies such as de novo Copy Number Variants [9].

Previous data suggest that the human gene Nascent polypeptide Associated Complex-alpha (NACA) is a candidate CHD gene that could provide novel insights into biological pathways in cardiac morphogenesis and pathogenesis. Using a GWAS approach, NACA was located within a genomic locus associated with increased myocardial mass [10], while Whole Exome Sequencing in families with Tetralogy of Fallot identified a single nucleotide polymorphism within NACA [11]. NACA is a highly conserved alpha subunit of a heterodimeric complex called Nascent polypeptide Associated Complex (NAC). Along with its heterodimeric partner, NAC-beta (NACβ/BTF3), NAC is one of several chaperones found near the ribosome exit tunnel that bind to select emerging nascent polypeptides [12]. NAC-ribosome complexes facilitate transport of nascent polypeptides to the mitochondria as has been demonstrated in yeast [1315]. At the ribosome exit site, NAC gates the activity of other nascent polypeptide chaperones. For example, NAC enhances the fidelity of Signal Recognition Particle (SRP) binding to only those nascent polypeptides destined for import to the Endoplasmic Reticulum (ER) [1618]. Depletion of NAC leads to promiscuous binding of SRP onto nascent polypeptides, drawing mistargeted ribosome-nascent polypeptide complexes to the ER for aberrant insertion into the membrane or secretion. NACA’s function as part of NAC therefore regulates the localization and posttranslational quality control of proteins in the cell.

In Drosophila, NAC plays an important role in translational regulation critical for embryonic development [19, 20]. Fly homologs of NAC subunits, Nacα and bicaudal (bic), were shown to repress protein translation of the posterior patterning gene oskar (osk) in anterior regions of the embryo, which was despite association of osk mRNA with polysomes, usually indicative of active translation. Restricting OSK protein translation and accumulation to the posterior pole of the embryo is critically required for patterning the posterior body plan [21]. Depletion of either Nacα or bic, expands OSK protein localization anteriorly resulting in a bicaudal phenotype, where the embryo develops with mirror-image duplication of the posterior axis [19, 22]. These studies suggest that within the developing embryo, NAC appears to regulate the expression of select proteins for proper spatial distribution. NAC could have a similar role in the timing and spatial targeting of translation within specific tissues.

Nacα has been demonstrated to be critical for development of several tissues using various model organisms. In mouse, the Nacα subunit can function as a transcriptional coactivator regulating bone development [2325] and hematopoiesis in zebrafish [26]. In vertebrates, a skeletal muscle- and heart-specific variant of Nacα has been associated with myofibril organization in zebrafish [27] and muscle and bone differentiation in mouse [2832]. Recent studies in the fly showed that Nacα knockdown (KD) specifically in the heart led to a ‘no adult heart’ phenotype [10], suggesting that Nacα could play a role in sarcomeric biogenesis, but its exact role in cardiac development had been unclear.

Here, we provide evidence for a cardiac developmental role for NAC and SRP in Drosophila and NACA in human Multipotent Cardiac Progenitors (MCPs). In flies, cardiac KD of NACα (mentioned above) and bic throughout development led to complete loss of the heart. We demonstrate that this phenotype is dependent on the timing of NACα KD, which requires KD during both embryonic heart development and pupal cardiac remodeling for a complete loss of the adult heart. KD in embryos only led to cardiac constriction and loss of the terminal chamber, while retaining heart structures in the anterior segments. KD of Nacα only during pupal stages did not affect adult heart structure. This suggests that NACα KD primes cardiac cells already in the embryo for aberrant responses to morphogenic cues during later developmental stages. Persistent Nacα KD during pupal stages remained required for complete loss of the adult heart. Consistent with this idea, NACα KD throughout cardiac development induced ectopic expression of the posterior patterning Hox gene Abdominal-B (Abd-B) into anterior regions of the remodeling heart during pupation. Concurrent KD of NACα and Abd-B significantly rescued the heart. This interaction between Nacα and Hox gene was recapitulated in MCPs, whereby NACA KD led to deviations in progenitor cell differentiation away from cardiomyocytes and toward fibroblast cell fates, which was reversed with combined KD of NACA and Hox genes HOXC12 or HOXD12. Because NAC associates and influences the activity of SRP, we tested the effects of individual SRP subunit KD on the fly heart. Interestingly, KD of individual SRP subunits produced cardiac phenotypes, some of which were distinctly different from NACα KD. These results suggest specific roles for ubiquitously expressed protein biogenesis factors NAC and SRP in heart morphogenesis, in part through alterations in the Hox gene expression. Translational regulation adds to our growing knowledge of biological pathways that may specifically contribute to cardiac pathogenesis leading to CHD.

Results

Knockdown of Nacα and bicaudal in the heart throughout development results in complete absence of the adult heart

The Nascent Polypeptide Complex (NAC) is a heterodimeric complex made of an alpha (NACA/Nacα) and beta (NACβ/BTF3/bicaudal) subunit that binds ribosomes to influence translation, protein folding, and transport of select nascent polypeptide chains. We investigated the role of the NAC complex, focusing on the alpha subunit, in the development and function of the Drosophila heart. Consistent with previously published data [10], knockdown (KD) of Nacα by RNAi (KK109114) using the Hand4.2-GAL4 driver [33] that is active in the heart tube, surrounding pericardial cells and wing-hearts throughout development, led to a ‘no-heart’ phenotype in adults when stained with phalloidin and the heart specific collagen, pericardin (Fig 1A and 1B). Similarly, KD of the β-subunit, bicaudal (KK104718), using Hand4.2-GAL4 led to a ‘no-heart’ phenotype (Fig 1C). Despite Nacα, or bic KD throughout heart development leading to the absence of hearts in adults, the posterior aorta and heart tube were still present in controls, Nacα KD, and bic KD during early pupae (<20hr After Puparium Formation, APF) as captured by in vivo imaging of fluorescently labeled hearts (Figs 1D–1F and S1A). We filmed and followed cardiac remodeling through pupation [13]. Normally, the heart undergoes remodeling through trans-differentiation of the larval aorta into the adult heart tube (Figs 1D and 3A and S1 Video). However, after 20 hours of puparium formation (APF) the hearts of cardiac Nacα KD flies began to disappear as cardiac remodeling progressed (Fig 1E and S2 Video). The space at the dorsal midline usually taken up by the heart, is now filled in with fat cells, indicating that the heart undergoes complete histolysis during remodeling. A similar course of events is observed when bicaudal is knocked down in the heart (Fig 1F and S3 Video). We also stained Nacα KD hearts with phalloidin just prior to cardiac remodeling (about 26–28 AFP), where heart tubes were present, but were narrower with disorganized actin filament arrangement (S1B Fig). KD with a second Nacα RNAi line (GD36017) led to formation of an adult heart, however, function was severely impaired and cytoskeletal structures were highly disorganized (S2A and S2B Fig). A second bicaudal RNAi line produced a no heart phenotype in adults (S2C Fig).

Fig 1. Knockdown (KD) of either subunit of Nascent polypeptide Associated Complex led to complete histolysis of the heart in adult flies.

Fig 1

Hand4.2-GAL4 driving heart specific expression of A, KK control B, Nacα-RNAi (KK v109114) or C, bicaudal-RNAi (KK v104718). KD of Nacα or bicaudal led to an absent heart in adult flies. * indicates absence of the heart tube. Arrowheads point to remnants of alary muscles that normally attach to the heart for structural support (anterior-left). Pericardin, a heart-specific collagen is largely absent, except for remnants in the posterior end. D, Representative still images from in vivo imaging movies (S1S3 Videos) of remodeling pupal hearts from control, Nacα, and bicaudal KD flies. During the first hours of pupation, the internal valves (yellow arrowheads) are visible which separate the larval aorta (anterior) and the heart (posterior) which we use as a landmark through remodeling. At about 14-20hr APF, these internal valves are present but the aorta is more difficult to visualize as the heart transdifferentiates. After 40hr APF, the remodeling adult heart tube is visible in controls with identifiable ostia structures (marked by a ^). In Nacα and bicaudal KD hearts, no heart tube is visible and the area is filled in by rounded fat cells (green arrowheads). The area of the embryo with fluorescent signal (circled) are remnants of histolyzed cardiomyocytes that slowly disperse and weaken in intensity. APFs are approximate due to developmental delays caused by reduced ambient temperatures in the microscope room.

Fig 3. Nacα and the Hox gene Abdominal B (Abd-B) genetically interact in the heart.

Fig 3

A, The embryonic/larval fly heart remodels into adult structures through trans-differentiation of the Ubx and abd-A expressing cardiomyocytes into the adult heart and terminal chamber, respectively. The cardiomyocytes of the posterior larval heart that express Abd-B (abdominal segment 6–7) histolyze and are absent in the adult heart. B, Overexpression of Abd-B in the heart using the cardiac driver Hand4.2-GAL4 led to complete absence of the adult heart, which in early stages of pupation was still present (see D). * indicates absence of the heart tube. C-E. Immunohistochemistry of pupal hearts 26–28 hours After Puparium Formation (APF). Dashed lines mark the region of the heart where orthogonal cross-sections were taken to examine Abd-B and DAPI expression in the nuclei. Images of the cross-section of cardiomyocytes and nuclei are displayed in the right panel. Arrowheads indicate either cardiac and pericardial nuclei that are both ABD-B and DAPI positive. C, In controls, phalloidin stained the circumferential fibers of the pupal aorta and heart. ABD-B staining was not detected in the cardiomyocyte nuclei within aorta and anterior heart segments but, ABD-B is stained in the posterior segments of the embryo. D, Overexpression of Abd-B using Hand4.2-GAL4 resulted in strong ABD-B staining in the nuclei (as indicated by the arrowheads) throughout the pupal heart and pericardial cells prior to remodeling. Cross section clearly shows that ABD-B is localized in the nucleus. E, Knockdown of Nacα in the heart resulted in ectopic ABD-B expression throughout the heart tube. Staining was present within the nuclei (marked by DAPI), cytoplasm and heart lumen (see orthogonal sections, right). F-H. Concurrent knockdown of Nacα and Abd-B in the heart, G, led to rescue of heart tube formation, with visible circumferential fibers (arrowheads) albeit less well-organized than controls. H, Rescued hearts were smaller in diastolic diameter with no change in systolic diameter resulting in reduced Fractional Shortening (FS). This effect was not due to titration of GAL4 onto 2 UAS sites, as combination of UAS-Nacα-RNAi with UAS-Val10-GFP still produced a no heart phenotype. I, Arrow indicates remnants of the ventral longitudinal muscle in the anterior end of the abdomen.

Using other cardiomyocyte-specific drivers, conferring different developmental expression patterns than Hand4.2-GAL4 to reduce Nacα levels, i.e. tinHE-GAL4 and tinCΔ4-GAL4, did not produce severe heart loss but altered several parameters of heart function and structure, as measured by SOHA (see methods; Fig 2A and 2B). Diastolic diameters were decreased using both drivers (Fig 2C) without a change in systolic diameter (Fig 2D), and consequently reducing contractility, as measured by diminished fractional shortening, FS (Fig 2E). No changes were detected in heart period (Fig 2F) and diastolic intervals (Fig 2G). KD of Nacα with tinCΔ4-GAL4 caused a slight reduction in systolic interval, which is the duration of active heart contraction and relaxation (Fig 2H). Phalloidin staining of the adult hearts with reduced Nacα expression showed gaps between the circumferential myofibrils and sarcomeric disorganization compared to controls, consistent with reduced contractility (Fig 2I). These results suggest that at certain expression thresholds and timing where heart development is not completely diverted, Nacα may play a role in functional and structural aspects of the heart as well. Because Hand4.2-GAL4 drives expression in both cardiac cells and the pericardial nephrocytes, we tested the effect of Nacα KD in pericardial cells only using Dot-GAL4 [34] to assess their contribution to the overall heart phenotype and reflect on the tissue specificity of Nacα KD effects. (Fig 2B–2H). KD in the pericardial cells did not produce significant changes in heart function, except for a slight increase in systolic diameter that did not change contractility (Fig 2D and 2E). The organization of the circumferential myofibrils as stained by phalloidin was unaltered compared to control (Fig 2I), suggesting that KD of Nacα in extra-cardiac cells, such as pericardial cells, contribute minimally to the overall cardiac phenotype.

Fig 2. Effect of Nacα knockdown (KD) using various GAL4 drivers on heart function and structure.

Fig 2

A,B Structural and functional parameters measured by SOHA to assess the fly heart. Dotted lines indicate the heart tube borders. White solid vertical lines indicate the diameters of the heart, while horizontal lines indicate the duration of contraction/relaxation being measured. A, Diastolic Diameter measures the heart diameter when it is fully relaxed, while systolic diameter measures the heart diameter when it is fully contracted. B, Motion-mode (m-mode) of the heart for temporal resolution of heart movement. Diastolic Interval measures the duration during which the heart is non-contractile, which occurs in this denervated fly preparation. Systolic Interval measures the duration that the heart is in active contraction and relaxation. C, Both tinHE-GAL4 and tinCΔ4-GAL4 cardiac drivers reduced Diastolic Diameter when used to KD Nacα expression (KK v109114). Dot-GAL4 pericardial cell driver had no effect on diastolic diameter. D, Cardiac drivers had no significant effect on systolic diameters, while Dot-GAL4 increased systolic diameter slightly, indicating mild systolic dysfunction. E, Fractional Shortening is significantly decreased using both tinHE-GAL4 and tinCΔ4-GAL4 driver, while Dot-GAL4 had no effect. No changes in Heart Period F, or Diastolic Interval G, were detected with either cardiac drivers or Dot-GAL4. H, A slight reduction in systolic interval was detected when Nacα-RNAi was driven with tinCΔ4-GAL4. I, Adult fly hearts were stained with phalloidin to examine cytoskeletal structures following Nacα KD using various tissue drivers. Compared to controls that display well- and tightly organized circumferential fibers that drive heart contractions, both tinHE-GAL4 and tinCΔ4-GAL4 drivers led to alterations in the organization of fibers. White arrowheads point to gaps in the fibers in KD samples consistent with the observed reductions in fractional shortening. KD of Nacα expression using Dot-GAL4 did not cause alterations in circumferential organization.

Nacα genetically interacts with the Hox gene Abd-B in heart development

We sought to better understand the mechanisms driving complete histolysis of the heart tube during metamorphosis. It is well established that during normal cardiac remodeling the posterior most segment of the larval heart (abdominal segments 6–7) that expresses the Hox segmentation gene Abdominal-B (Abd-B) histolyzes and is no longer present in adult hearts (Fig 3A) [3538]. Abdominal segment 5 in the larvae that expresses the Hox segmentation gene abdominal-A (abd-A) remodels to become the adult terminal chamber, while the larval aorta (abdominal segment 1–4) that expresses Hox gene Ultrabithorax (Ubx) remodels to become the adult heart proper. We postulated that KD of Nacα throughout the heart could result in the misexpression of Abd-B leading to complete histolysis of the heart. First, we examined whether overexpression of Abd-B throughout the heart would result in similar phenotypes as with Nacα KD. Previously published data overexpressing Abd-B using an early pan-mesodermal driver (twist-GAL4) led to severely diminished embryonic muscle and heart development [39]. Using the cardiac-specific driver Hand4.2-GAL4 to overexpress Abd-B, the heart was completely absent in adults (Fig 3B, right), however a heart tube was present in larvae and in early pupae (24 hours APF, Fig 3D), similar to control (Fig 3C) Nacα-RNAi (Fig 3E) and bic-RNAi phenotypes (Fig 1). These results suggest that Abd-B expression and developmental activity are highly temporally controlled, and drive cardiomyocyte histolysis only during cardiac remodeling at pupal stages.

We then examined whether KD of Nacα leads to ectopic expression of Abd-B protein in the early pupal heart just prior to remodeling (APF 26–28). In controls, Abd-B protein is undetected in the anterior regions of the early pupal heart tube (Fig 3C), but detected in the posterior segments of the embryo. Overexpression of Abd-B using Hand4.2-GAL4 led to increased ABD-B protein accumulation throughout the early pupal heart tube and pericardial cells, which was restricted to the nuclei (Fig 3D). When Nacα was knocked down in the heart, we detected ABD-B protein expression throughout the larval/early pupal heart tube, within the myocardial nuclei as well as in the cytoplasm (Fig 3E). In orthogonal sections, there is ectopic ABD-B staining centrally, possibly within the lumen of the heart, either secreted from cardiomyocytes or bound to circulating hemocytes. These data suggest that KD of Nacα in the heart led to ectopic expression of ABD-B within the cell, as well as, anteriorly throughout the heart tube. Because overexpression of Abd-B using Hand4.2-GAL4 led to heart histolysis during remodeling, we speculate that ectopic ABD-B expression induced by Nacα KD could be leading to the observed histolysis of the entire heart during remodeling.

Because Nacα KD led to ectopic expression of ABD-B, we tested whether the no-heart phenotype produced by Nacα KD could be rescued by concurrent KD of Abd-B. KD of Abd-B alone led to largely intact hearts except for posterior ends that were more dilated and prominent compared to controls suggesting incomplete histolysis during cardiac remodeling, as expected (S3 Fig). KD of both Nacα and Abd-B using the Hand4.2-GAL4 driver led to a remarkable rescue of the adult heart, restoring formation of most of the circumferential myofibrils in the anterior regions (Fig 3F and 3G). These hearts had reduced diastolic diameters, significantly reduced fractional shortening (Fig 3H). This rescue was not due to titration of GAL4 protein by competing UAS sites, since a no-heart phenotype was still produced when Nacα-RNAi was combined with another UAS that carries a UAS-Val10-GFP construct (Fig 3I). These rescue data suggest a genetic interaction between Nacα and Abd-B.

Rescue by Abd-B-RNAi was not observed in the wing, where Nacα KD leads to fluid filled blisters in almost all flies, likely due to defects in wing-heart function (S4 Fig). Co-expression of Nacα-RNAi and Abd-B-RNAi did not improve the wing blisters nor reduce their penetrance (S4C and S4D Fig), while Abd-B KD by itself did not affect wing heart function (S4A and S4B Fig) or cause heart loss (S3 Fig), suggesting that the interaction and rescue may be cardiac tissue specific. Furthermore, KD of the Hox gene abd-A in combination with Nacα-RNAi did not rescue the loss of the heart (S5A Fig). KD of Nacα-RNAi resulted in reduced ABD-A protein staining in pupal hearts (S5B Fig), opposite of what we see with ABD-B protein levels (Fig 3E). Combined Nacα-RNAi with abd-A overexpression led to lethality at pupal stages. These data demonstrate the specificity of the cardiac rescue with the Hox gene Abd-B but not abd-A. Lastly, co-expression of Nacα-RNAi with an inhibitor of apoptosis (Death-associated inhibitor of apoptosis 1, DIAP1) did not rescue the heart (S6 Fig), suggesting that the Nacα-RNAi mediated heart loss cannot simply be prevented by inhibition of canonical cell-death pathways.

We also tested whether Abd-B KD could rescue the cardiac function defects produced by less robust KD of Nacα, using the tinHE-GAL4 driver, that drives moderate expression in cardiomyocytes during embryonic and pupal development and in the adult. Nacα KD with tinHE-GAL4 caused cardiac constriction but no effects on heart period or intervals (S7A and S7B Fig). KD of Abd-B using tinHE-GAL4 did not produce significant changes in heart function compared to controls, except for a prolonged systolic interval. Combining Nacα-RNAi with Abd-B-RNAi reversed the constricted diastolic and systolic diameter phenotype of Nacα-RNAi;UAS-Stinger::GFP, such that the phenotype mirrored controls or Abd-B-RNAi;UAS-Stinger KD. An improvement in circumferential myofibrillar organization is also evident with co-KD of Nacα and Abd-B (S7C Fig). These data suggest that Abd-B and Nacα co-KD restored heart formation with the strong Hand4.2 driver, and also normal heart function and myofibrillar organization with the weaker tinHE-GAL4 driver. This means that functional maturation requires Nacα to restrict Abd-B function to the posterior of the heart.

Nacα is required in the embryo to pre-program cardioblasts for appropriate cardiac remodeling

Prior to pupal cardiac remodeling, a larval heart was still present despite Nacα KD using the strong cardiac driver Hand4.2-GAL4 (Figs 1E and 3E). However, these larval heart tubes were thinner and the cytoskeletal structures less prominent than controls (Figs 3E and S1B), reminiscent to the constricted adult heart phenotypes with the weaker driver tinHE-Gal4 (Figs 2 and S7). These observations suggest that Nacα may have earlier developmental functions in addition to a role in metamorphosis. We therefore wanted to temporally dissect Nacα’s function in the heart by knocking down its expression during different developmental stages. We generated a Hand4.2-GAL4 driver line that included two copies of a temperature-sensitive allele of GAL80 driven by a ubiquitous promoter (tubulin-GAL80ts), which we termed HTT [9]. At the permissive temperature (18°C), the GAL80 transcriptional repressor prevents GAL4 activation of UAS sites thereby inhibiting transcription of downstream constructs [40]. This temperature-sensitive form of GAL80 protein is unstable at higher temperatures (28–29°C), thus permitting GAL4 activity at higher ambient temperatures.

Maintaining HTT flies crossed to Nacα-RNAi or controls at 18°C throughout development resulted in normal heart structure (Fig 4A) and produced no differences in diastolic diameter, systolic diameter or fractional shortening compared to controls (Fig 4I), effectively demonstrating GAL80’s ability to suppress Nacα-RNAi transcription at 18°C temperatures. Constant exposure to 28°C throughout development phenocopies the absence of the heart in adults produced by Hand4.2-GAL4 driver (Fig 4B). KD of Nacα in adults only for one week by exposure to high temperatures led to largely normal heart structure and function compared to controls (Fig 4C and 4I), suggesting that Nacα is primarily required developmentally for establishing a normal heart in adults, rather than maintaining its function or structure with age. Remarkably, although lifelong cardiac Nacα KD using Hand4.2-GAL4 led to histolysis of the heart during metamorphosis, KD of Nacα during pupation only (~3 days at 28°C) did not produce gross heart defects (Fig 4D). The diastolic and systolic diameters were slightly increased, which caused some reduction in fractional shortening (Fig 4I). Even when we induced Nacα KD earlier, starting at mid-larval stages through metamorphosis until eclosion (~5 days at 28°C), a period with substantial developmental growth requiring high levels of protein translation, heart structure was unaffected (Fig 4E). This lack of phenotype is remarkable, as disruption of NAC is associated with proteostasis and ER stress, which often leads to cell death [4143]. These results suggest that KD of Nacα in the developing heart, even for relatively long durations does not unequivocally lead to cell death. When Nacα was knocked down during embryonic stages only (egg-lay up to 24 hours) and subsequently reared at 18°C until dissection to prevent Nacα KD at later stages, most adult hearts remained intact, but considerably constricted with smaller diastolic and systolic diameters (Fig 4F and 4I). Interestingly, the posterior terminal heart chamber was absent in most cases (Fig 4F), which suggests that the no-heart phenotype observed with continuous KD likely arises from developmental defects already in the embryo. Extending exposure to higher temperature during embryonic stages until 48 hours after egg lay, produced similar phenotypes compared to 24hr exposure, with the presence of a heart tube but without a terminal chamber (Fig 4G). Remarkably, when flies were exposed to higher temperatures during both embryonic stages (24 hours) and pupal stages (3 days; for a total of 4 days), with a return to 18°C during larval development, an almost complete ‘no-heart’ phenotype was reproduced in most cases (Fig 4H). This suggests that Nacα KD only during combined embryonic and pupal stages produces a nearly complete loss of heart structures, but at either stage alone was insufficient for such a severe phenotype.

Fig 4. Temporal regulation of Nacα-RNAi expression in the heart.

Fig 4

Using a temperature inducible driver specifically in the heart (HTT, Hand4.2-GAL4, tubulin-GAL80ts; tubulin-GAL80ts), Nacα-RNAi was expressed during specific stages of development by controlling ambient temperature to determine its contribution to cardiogenesis. Controls lacking RNAi are kept in similar temperature conditions to account for any developmental effects of temperature on the heart. A-H. Phalloidin staining to visualize cytoskeletal structural effects of Nacα knockdown (KD). A, As a test of GAL80 control of transcription, flies held at 18°C throughout development did not produce changes to heart structure indicating an inhibition of Nacα-RNAi transcription. B, Exposing flies to high temperatures (28°C) throughout development produced a no heart phenotype similar to the effects of driving Nacα-RNAi using Hand4.2-GAL4 alone, suggesting an induction of Nacα-RNAi transcription and subsequent Nacα KD with exposure to higher temperatures. * indicates absence of the heart. C, Exposing flies to high temperature during adulthood only for 1 week, D, pupae to eclosion, or E, mid-larvae to eclosion did not produce gross structural defects in the heart. F, Exposing embryos to high temperatures starting at egg-lay up until 24 hours resulted in the absence of the terminal chamber, indicated by white bar. Only thin alary muscles were present. G, Extending the high temperature exposure to 48 hours led to similar loss of the posterior heart, indicated by white bar. H, Only when the hearts were exposed to higher temperatures during embryonic stage (24 hours) and pupal stage until eclosion (~3 days), were we able to recapitulate the no heart phenotype produced by exposing the heart to constant high temperatures. I, Functional analysis of the adult heart following Nacα KD at various developmental stages. Maintaining flies at 18°C throughout development or exposure of adult flies to high temperature for 1 week led to no changes in diastolic diameter, systolic diameter, or fractional shortening. High temperature exposure from pupae to eclosion or from mid-larvae to eclosion led to subtle changes in diameters and fractional shortening. Exposure of embryos to high temperatures for 24hr led to constricted diastolic and systolic diameters. * p<0.05, ** p<0.01, *** p<0.001.

We measured Nacα mRNA expression in adult hearts of HTT flies subject to pupae only Nacα KD (S8 Fig). We detected significantly reduced Nacα expression shortly after eclosion, suggesting that despite reduced Nacα levels, the heart remodels into a largely normal heart (Fig 4D). We also measured Nacα mRNA levels in early pupal hearts, that were subject to Nacα KD only in the embryo (24 hours) before being returned to 18°C (S8 Fig). Interestingly, we also found reduced Nacα mRNA levels in early pupae at the onset of metamorphosis, suggesting that embryonic KD of Nacα reprograms cells leading to longer term effects such as reduced Nacα expression later in development even without RNAi induction. This reduced Nacα expression early in pupae leads to changes in cardiac remodeling and constricted adult hearts (Fig 4F and 4I). However, this is still insufficient to completely histolyze the heart, unless subject to additional KD during pupal stages. Some extra-cardiac tissues are also collected during heart dissection in pupae and adult, such as few fat and muscle cells where Hand4.2-Gal4 is not expressed, thus the level of Nacα KD is likely an underestimation.

These results suggest that Nacα’s role in driving heart morphogenesis has a temporal component, perhaps regulating several different processes during cardiac development. Furthermore, the observation that Nacα KD during embryonic as well as pupal stages is needed to induce histolysis of nearly the entire heart tube during pupal cardiac remodeling suggests that Nacα plays an essential role in embryonic heart development by programing cardiac cell fate. This embryonic requirement seems to be partially compensated for by sufficient Nacα function during heart remodeling. However, additional reduction of pupal Nacα exacerbates the changes in embryonic cardioblast programming, together leading to a failure of the larval heart to respond to remodeling cues during metamorphosis, thus causing histolysis.

Nacα alters cell-fate in human Multipotent Cardiac Progenitors and is modulated by Hox genes

Since our results suggest that Nacα plays a role in establishing cell identity and cell-fate of cardiac cells in Drosophila, we wanted to determine whether a similar role could be observed in other model systems, such as cardiomyocytes derived from human iPSCs (hiPSCs). We subjected human iPSC-derived Multipotent Cardiac Progenitors (MCPs) [44] to siRNAs against the human ortholog of Nacα, NACA, to assess their effects on cell proliferation and differentiation (Fig 5) [9]. We evaluated the propensity for MCPs to spontaneously differentiate into different cell types and calculated their relative proportions, by staining with α-Actinin1 (ACTN1) for cardiomyocytes (CM), Transgelin (TAGLN) for fibroblasts, and Cadherin 5 (CDH5) for endothelial cells. Total cell number was quantified by counting the number of DAPI-positive nuclei. The proportion of differentiated cell types was assessed nine days after siRNA treatment, a timepoint when active KD is no longer expected [9].

Fig 5. Nacα and Hox genes interact to redirect differentiation of Multipotent Cardiac Progenitors (MCPs).

Fig 5

A,C,E, Quantitation of differentiated cell populations 9 days after siRNA treatment. B,D,F. Representative images of immunohistological staining for select conditions. A,B, Total Cell Populations following siRNA treatment were not significantly changed compared to controls, except for Gata4/6,MyoCD siRNA condition which reduced overall cell count. Knockdown (KD) of Nacα (green), HOXC12 (light blue), HOXD12 (light gray) singly resulted in cell populations that trended lower. This decrease was reversed and significantly different upon combined transfection of Nacα siRNAs with Hox genes, compared to single siRNA transfections. C,D, Nacα KD alone significantly decreased the proportion of cardiomyocytes (ACTN1+) compared to controls, while treatment with HOXC12 or HOXD12 siRNA individually, had no effect. Combined transfection of Nacα and Hox genes reversed the decrease in cardiomyocyte population and was significantly different compared to Nacα KD alone and no longer different compared to controls. Gata4/6,MyoCD KD also significantly lowered the proportion of cardiomyocyte populations. E,F, Nacα KD increased the proportion of fibroblasts (TAGLN+) compared to controls. Combined KD of Nacα with any of the Hox genes did not alter fibroblasts numbers compared to controls but were significantly reduced compared to Nacα KD alone. G, Images of merged staining of cardiomyocyte, fibroblast, and endothelial cells shows the decrease in cardiomyocyte (red) and increase in fibroblast (green) staining when NACA is knocked down compared to controls. This is reversed upon co-KD with HOXC12 and HOXD12. Significance * vs. control. ^ vs. Nacα. # comparison is indicated by line. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.

Treatment of MCPs with NACA siRNA did not change total cell count compared to controls (Fig 5A and 5B), but significantly decreased the proportion of CMs (Fig 5C and 5D), and increased the proportion of fibroblast (Fig 5E and 5F). The proportion of endothelial cells remained unchanged (S9A and S9B Fig). These results suggest that NACA may play a role in directing cell fate toward a cardiac program and its absence shifts these fates toward fibroblast differentiation.

We wondered whether the effect of NACA on CM differentiation can be similarly reversed by human orthologs of Drosophila Abd-B. Therefore, we tested the effect of siRNAs against human Homeobox C12 (HOXC12) or Homeobox D12 (HOXD12), which have close sequence homology with Abd-B. Treatment of either HOXC12 and HOXD12 siRNAs individually did not have a significant effect on total (Fig 5A), cardiomyocyte (Fig 5C), fibroblast (Fig 5E), or endothelial (S9A Fig) cell populations compared to controls. When we tested combinations of NACA siRNA with HOXC12 and HOXD12 siRNA, or all three, we found that the Hox genes could alter NACA phenotypes. While treatment with NACA siRNA led to a reduced trend in total cell populations, combined KD of NACA and HOXC12 and HOXD12 led to total cell populations that were significantly higher than NACA siRNA treatment alone and were more similar to controls (Fig 5A and 5B). More striking is the reversal in the proportion of cardiomyocyte and fibroblast populations when NACA siRNA was combined with HOXC12 and HOXD12. Co-transfection of NACA with the selected Hox genes led to increased CM (Fig 5C and 5D) and reduced fibroblasts (Fig 5E and 5F) such that they are significantly different compared to NACA siRNA treatment alone and no longer different compared to controls. Efficiency of siRNA KD following transfection is expected to be maintained even when siRNAs against 3 different gene targets are combined, as demonstrated in previous experiments [7, 9]. These results suggest that the reduction in CM and increase in fibroblast caused by NACA KD is dramatically rescued upon Hox co-KD, thus restoring CM differentiation of these pluripotent cells (Fig 5G). It remains possible that NACA interacts with other Hox genes not tested here, in mammalian cardiac tissue to direct morphogenesis. Furthermore, overexpression of Hox genes alone would be expected to have an effect on the ratio of cardiomyocyte and fibroblasts and their interaction with NACA could also be explored. These results are consistent with observed cardiac differentiation and genetic interactions in Drosophila and that Nacα/NACA activity in the heart may in part be mediated by posterior Hox genes.

As a positive control and a means of comparison, we transfected MCPs with siRNAs against cardiogenic transcription factors GATA Binding Protein 4 and 6 (GATA4/6) and Myocardin (MYOCD) [45, 46]. GATA4/6,MYOCD KD caused a significant decrease in total cell number (Fig 5A and 5B) and proportion of cardiomyocytes (Fig 5C and 5D), no change in the proportion of fibroblast (Fig 5E and 5F), and an increase in the proportion of endothelial cells (S9A and S9B Fig). Thus, the effect of NACA KD on the proportion of cell types were different compared to the cardiogenic factors. The only similarity observed between NACA and GATA4/6,MYOCD KD was a decrease in the proportion of cardiomyocytes, although NACA produced a greater decrease (Fig 5C and 5D). These results suggest that NACA KD induced alternate cell fates, possibly by a different mechanism to that of these cardiogenic transcription factors.

Knockdown of individual SRP subunits cause distinct cardiac phenotypes

NAC is just one of the protein biogenesis quality control mechanisms that is found at the ribosomal exit site sifting through emerging nascent polypeptides and guiding protein fates. SRP is another protein complex involved in controlling protein biogenesis by binding a disparate subset of nascent polypeptides destined for the ER, wherein its targeting is influenced by the activity of NAC. Therefore, we wanted to examine if disruption of SRP function in fly hearts would result in similar defects compared to Nacα KD. Eukaryotic SRP is composed of a 7SL SRP RNA that holds the conformation of 6 proteins (SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72) and targets approximately 30% of newly synthesized proteins to the ER (Fig 6A) [47]. SRP primarily recognizes the N-terminal hydrophobic sequences of emerging nascent polypeptides, but has also been shown to bind nascent chains even when target sequences are not yet accessible [48]. In yeast, SRP also binds nascent chains with internal transmembrane domains [49]. Once bound, SRP arrests translation of the nascent chain until the SRP-ribosome complex binds with the SRP-receptor (SR) anchored to the ER, where translation of the nascent chain is restarted and co-translationally released through the Sec61p translocase for insertion.

Fig 6. Knockdown (KD) of SRP subunits in the Drosophila heart caused distinct heart defects.

Fig 6

A, The Signal Recognition Particle (SRP) is composed of an RNA molecule holding together 6 SRP subunits. B-M, Individual SRP subunits were KD by RNAi using the heart specific driver Hand4.2-GAL4 and adult flies were stained with phalloidin to determine their contribution to heart structure and development. * indicates missing heart segments or cardiomyocytes. KD of C, SRP9 and D, SRP14 subunits, responsible for elongation arrest during translation, did not lead to gross alterations in heart structure and were comparable to B, controls. Arrowhead in control image point to the conical chamber. E, KD of SRP68 led to complete loss of the heart. G, Interestingly, KD of SRP72, a binding partner to SRP68 led to the presence of a heart tube. H, Higher magnification of the conical chamber, marked by an arrowhead, showed that the conical chamber was constricted compared to controls (B), and resembled a larval aorta. F, KD of SRP19, led to a partial heart phenotype, where the anterior region of the heart was absent but the posterior end remained. I, KD of SRP54 led to a heart tube but with missing heart cells (indicated by asterisks) in random regions of the heart. J, Higher magnification of missing cardiomyocyte. K, KD of the SRP Receptor-β, a subunit of the receptor anchored to the ER membrane that binds to the SRP-ribosome-nascent chain complex, led to segments of the heart, usually the valves, that were constricted and larval like, indicated by the arrowhead. L, Higher magnification of the narrowed heart tube. Ostia structures are still present as marked by ^. M, As comparison, valve cells in controls (marked by arrowhead) are wider than SRPβ KD and are densely packed with myofibrils.

Each subunit of the SRP complex exhibits specialized roles in the binding and translocation process (Fig 6A) and therefore, each subunit could confer specialization of SRP function through recruitment of cofactors or selective targeting of nascent proteins. We therefore knocked down each of the SRP subunits individually, as well as the β-subunit of SRP Receptor (SRPR-β), to explore their role in heart development and how their phenotypes compare to NACα and bic KD. We used two different RNAi lines when available and showed examples of RNAi lines with more severe phenotypes (S1 Table). RNAi mediated KD of either Srp9 or Srp14 subunits in the heart driven by Hand4.2-GAL4 using two different RNAi lines did not produce gross differences in the heart structure compared to controls (Fig 6B–6D). In contrast, KD of Srp68 led to complete absence of the adult heart, similar to Nacα KD (Fig 6E). Upon KD of Srp72, the heart tube was still present which is unlike the Nacα KD phenotype. The very anterior segment, called the conical chamber, remained very constricted, reminiscent of its larval structure (Fig 6G and 6H). This larval aorta-like structure suggests that this section of the heart failed to undergo remodeling during metamorphosis. KD of Srp19 led to a partial heart phenotype, where the anterior segment of the adult heart tube is absent, but retained a posterior segment, including the terminal chamber (Fig 6F), again unlike what was observed with Nacα KD. KD of Srp54, which recognizes and binds the signal sequence on the nascent polypeptide, led to a malformed heart with missing cardiomyocytes in random positions throughout the tube (Fig 6I and 6J). KD of SR-β led to a heart tube with missing cardiomyocytes, which were most often the internal valves of the heart (Fig 6K–6M). Interestingly, in vivo imaging of fluorescently labeled hearts in early pupae demonstrated that an intact larval heart tube forms with KD of any SRP components (S10 Fig), suggesting that their requirement prior to pupal remodeling of the heart may be less critical. Considering Srp19 and Srp68 KD largely abolished adult hearts, the presence of an intact heart tube prior to cardiac remodeling in pupae suggests, that like NACα, their activity is critically required during cardiac remodeling and morphogenesis.

In summary, the KD of individual NAC and SRP subunits led to a range of distinct cardiac phenotypes that suggests each subunit and complex may function with distinct cell-type, regional and temporal specificities during cardiac development. Further characterization of SRP phenotypes in the embryo and during metamorphosis, measuring the magnitude of knockdown of each SRP subunit, and proteomic analysis would help decipher whether each subunit contributes specialized function in development and interacts with other cofactors that could target subsets of genes differently between SRP and NACα.

Discussion

Nascent polypeptide Associated Complex (NAC) and the Signal Recognition Particle (SRP) are integral to protein biogenesis. Our work suggests that they are pertinent for establishing distinct proteomic landscapes that shape cell identity and direct developmental fates (Fig 7). We demonstrated a developmental role for the NAC subunit Nacα, in the Drosophila heart (Figs 1 and 2) and Human Multipotent Cardiac Progenitors (MCPs; Fig 5) that influenced cardiac cell identity and morphogenesis through associations with Hox genes (Fig 3). These cardiac defects were triggered by knockdown (KD) of Nacα at specific stages in development (Fig 4). Similarly, disruptions in SRP subunit expression led to cardiac cell type specific defects in the fly with some changes in heart morphology occurring during later, critical stages of development (Fig 6). These results suggest that Nacα function and interaction with select protein targets were temporally regulated and that SRP subunits could function similarly. Components involved in protein translation are a growing family of genes associated with tissue-specific and developmental defects [50], including the heart [51, 52]. For example, in mice, mutants of the ribosomal protein Rpl38 displayed specific axial skeletal patterning defects attributable to reduced protein levels of a subset of Hox genes (HOXA5, HOXA11 HOXB13) without changes in global protein translation [53, 54]. Patients with Diamond Blackfan Anemia (DBA), a bone marrow failure syndrome caused by ribosomopathies, exhibit higher manifestations of CHD compared to the general population [55]. In other cases, ribosomopathies led to CHD defects without overt hematological abnormalities [9, 56, 57]. Nacα specifically has been associated with Tetralogy of Fallot [11] and increased myocardial mass [10]. Within the SRP pathway, SRP54 mutations cause Schwachman-Diamond-like syndrome, a condition associated with CHDs [58, 59]. Furthermore, within the Pediatric Cardiac Genomic Consortium cohort [60], the SRP Receptor-α was associated with atrial septal defects while SRP Receptor-β was associated with cyanotic congenital heart disease including ventricular septal defect. As genomic studies of patients uncover new variants associated with CHD, a closer examination of variants within translational genes and their co-occurrence with gene variants within developmental genetic networks is warranted.

Fig 7. A schematic diagram of protein translation at the ribosome exit site.

Fig 7

Nascent polypeptide cofactors NAC and SRP select for gene targets, regulating their expression in a tissue and/or cell specific manner to regulate heart morphogenesis. Our work suggests that the posterior determining Hox gene Abd-B is a target of Nacα, as the knockdown of Nacα led to Abd-B misexpression and disruption of heart morphogenesis through failure of cardiac remodeling during metamorphosis. Knockdown of SRP subunits each led to distinct heart defects: SRP72 knockdown disrupted conical chamber morphogenesis, SRP-Rβ targeted internal valve cells, SRP54 led to missing cardiomyocytes, SRP19 led to loss of anterior segment of the heart, while SRP68 led to a no heart phenotype similar to Nacα knockdown. Future work can help uncover the nature of the distinct phenotypes whether due to dissimilar KD levels or targeting of unique transcripts by individual SRP subunits to direct different cell fates.

It is remarkable that the complete histolysis of the adult fly heart observed during pupal stages required KD of Nacα during both embryonic and pupal stages, either one alone was not sufficient (Fig 4D–4H). This was surprising, since during pupal stages the heart undergoes extensive remodeling, requiring significant protein biogenesis. Yet, pupal-only KD (or mid-larval to eclosion KD) of Nacα did not induce cell death, nor cause significant changes in heart structure or function. This suggests that Nacα function during embryonic stages may create a proteomic landscape establishing long-term programming of cardiomyocyte identity properly poised for future developmental responses, such as remodeling to the adult heart during metamorphosis. An embryonic requirement for later cardiac remodeling and survival was also found for ribosomal protein gene RpL13 [9]. However, in the case for RpL13, KD in the embryo alone resulted in significant heart loss during later developmental stages. Thus, again translational perturbances in the embryo can have long-lasting effects, suggesting a mechanism by which preprograming in the embryonic heart is critical for appropriate cardiac remodeling later in development. How translational proteins and mechanisms contribute to redefining cell identity would need to be better understood.

Our studies found that KD of Nacα restricted by Hand4.2-GAL4 to mid- to late stages of embryo development (beginning stage 14 until hatching) specifically in cardiac relevant cells induced posterior terminal heart chamber defects that were evident in adult morphology (Fig 4E and 4F). This suggests spatial specificity in Nacα function with embryonic origins targeting posterior cardiac cells more severely compared to more anterior regions. We also demonstrated that Nacα genetically interacts with a posteriorly expressed Hox gene, Abd-B, later during pupal stages, which further supports a stronger requirement for Nacα in posterior heart patterning (Fig 3). The KD of Nacα in cardiac cells permits ABD-B protein expression in the anterior regions of the larval heart and aorta, where it is normally absent (Fig 3C–3E). Ectopic ABD-B expression could occur through direct disinhibition of Nacα translational control of Abd-B mRNA. Alternatively, Nacα KD could have an indirect effect on cell identity that aberrantly turns on Abd-B transcription and subsequent protein expression. The regional specificity in Nacα activity is consistent with a previously described role for NAC in the posterior patterning of the developing Drosophila embryo [19, 20]. In the embryo, posterior patterning proteins, such as OSKAR and NANOS, accumulate in the posterior end of the embryo. Components of the NAC complex were necessary to restrict mRNA localization of OSKAR and NANOS to the posterior end and spatially restricting their subsequent translation [19, 20]. Absence of NAC components resulted in ectopic expression of posterior patterning proteins anteriorly leading to a lethal, bicaudal phenotype. Future studies will be aimed at determining the mechanisms that regulate Nacα activity that drives these anterior-posterior specific responses in the heart, including the regulation of Abd-B expression and activity. The failed rescue by the more anteriorly expressed Hox gene abd-A as well as the low protein sequence homology outside of the highly conserved homeodomain amongst Hox protein is consistent with a specific interaction between Nacα and Abd-B. Hox genes play a crucial role in early cardiac specification, patterning and remodeling [61] and Nacα translational regulation could be a novel mechanism of regulating Hox genes as well as other cardiac relevant targets that may contribute to pathogenesis of CHD.

Our work using MCPs demonstrated a role for Nacα in human cardiac cell specification and differentiation. KD of Nacα redirected progenitor cell fates from a cardiomyocyte lineage toward a fibroblast lineage (Fig 5), a population profile that was distinct from KD of cardiogenic transcription factors Gata4/6 and MyoCD (Fig 5) [62, 63]. This suggests that Nacα utilizes distinct mechanisms for refinement of cardiac cell fates, but it remains to be determined how these processes are coordinated. Interactions between Hox genes and Nacα were also consistent between flies and mammalian cells and thus have implications for Hox gene mediated anterior-posterior patterning crucial for proper morphogenesis in mammals. Complex signaling events coordinate patterning of cardiac progenitor populations within subdivided domains defined by unique transcriptional programs contributing to the development of distinct heart structures [64]. Transcriptional profiles within these subdomains have implicated specific Hox gene expression (i.e. Hoxa1 and Hoxb1) to establish cellular identity and cell fate [64, 65]. Future work in mammals can determine whether NAC and SRP activity contribute to targeted expression of Hox genes within distinct subdomains, as suggested by our work in flies and human MCPs.

Protein biogenesis and its regulation at the ribosome exit site relies on a network of nascent protein chaperones. Because of the interactions between NAC and SRP that refine their ability to target specific nascent polypeptides emerging from ribosomes, we explored the effects of disrupting SRP activity on fly heart development and compared them to Nacα KD. KD of individual SRP subunits led to unique and varied cardiac phenotypes (Fig 6). Furthermore, SRP’s influence on cardiogenesis is temporally regulated, as gross changes in morphology occur during crucial developmental stages, such as the disappearance of the heart during metamorphosis induced by Srp68 KD (Figs 6E and S6). Further characterization of SRP function in heart morphogenesis will be focused on whether individual SRP subunits contribute to cell-fate specific translational activity through interactions with differentially expressed cofactors. This would help clarify the distinct cardiac phenotypes induced by KD of each subunit and uncover novel aspects of protein biogenesis control in a cell-type specific manner. In contrast to Nacα, the SRP complex targets nascent proteins destined for insertion into the rough ER and subsequent translocation to the plasma membrane or for secretion. Therefore, SRP targets are likely enriched for membrane receptors. Thus, interruption of receptor function and non-cell-autonomous signaling may be partially involved in the cardiac phenotypes caused by disruption of SRP activity. For example, cardiac cells may respond aberrantly to ecdysone steroid hormone secreted by the ring gland during metamorphosis due to a lack of Ecdysone Receptor expression at the cardiac cell membrane. Indeed, this may in part be a contributing mechanism, as Srp72 KD in the heart resulted in constriction of just the conical chamber in the anterior region of the adult heart, which resembled an unremodeled larval heart (Fig 6G and 6H), as previously observed for inhibition of Ecdysone Receptor function [38, 66]. Still, why there appears to be regional specificity to this lack of Ecdysone Receptor response, despite Srp72 KD throughout the heart, remains to be determined.

In summary, our work demonstrated specific roles for the NAC and the SRP complex in cardiac development, using Drosophila and human MCPs, and offers novel mechanisms in the regulation of the cardiac proteome to establish cell identity and tissue patterning (Fig 7). How generic components of the translational machinery could lead to targeted effects on heart development and function is likely layered in a complex process that remains to be explored.

Materials and methods

Drosophila strains

Heart-specific control of transcription was achieved by the GAL4-UAS system [67], in which the following cardiac relevant GAL4 drivers were used: Hand4.2-GAL4 [33, 68, 69], tinCΔ4-GAL4 [70], tinD-GAL4 [71], and tinHE-GAL4 [72]. Dot-GAL4 driver line [34] was used to express in pericardial cells. Drosophila GD and KK RNAi collection lines along with appropriate controls were obtained from the Vienna Drosophila Resource Center (VDRC) [73]. KK and GD controls are the original background fly line wherein the RNAi construct was inserted. Two copies of a temperature-sensitive tubulin-GAL80 (tubulin-GAL80ts) were recombined and combined with the Hand4.2-GAL4 driver (Hand4.2-GAL4, Tubulin-GAL80ts; Tubulin-GAL80ts, HTT; [9]). All fly lines are listed in S1 Table.

Developmental regulation of gene expression

The HTT line allows for transcriptional control of constructs fused to a UAS enhancer by manipulation of ambient temperature. At 18°C, GAL80 is intact and blocks GAL4 mediated activation of the UAS enhancer. A shift to 29°C destabilizes GAL80 protein, permitting GAL4 binding to the UAS enhancer to induce transcription. As control, flies were placed in 18°C or 28°C throughout development until eclosion when an intact or an absent heart were expected, respectively. For Nacα knockdown (KD) in embryonic stages, female and male flies were placed in 29°C and embryos collected every 2 hours. Embryos were maintained in 29°C for 24 hours and then shifted to 18°C for the remainder of development. Another set of embryos were maintained in 29°C for 48 hours before shifting to 18°C. For Nacα KD during pupal stages, fly crosses were maintained in 18°C until wandering 3rd instar larvae were collected. They were then immediately placed in 29°C until eclosion. For KD of Nacα starting at mid-larvae, embryos from fly crosses at 18°C were collected every 2 hours, maintained in 18°C for 16 days when larvae were approximately at L2 stages. Larvae were then placed in 29°C until eclosion. Finally, to test Nacα KD during embryonic and pupal stages only, embryos were collected from fly crosses at 29°C for 24 hours as described above, and then returned to 18°C to develop through larval stages. Wandering larvae were then collected and then placed in 29°C until eclosion. Adult flies were assessed for heart function using SOHA (see below) and immunostained to examine structure (see Fig 4).

Immunostaining of adult drosophila hearts

Adult flies were dissected and treated with 10mM EGTA in PBT (PBS + Triton-X-100; 0.03% Triton X-100), for 2 minutes to maintain a relaxed state of the heart. Hearts were then fixed with 4% PFA in PBT for 20 minutes, followed by three 10-minute PBT washes. Hearts were stained with primary antibodies (EC11 Pericardin and Abd-B from Developmental Studies Hybridoma Bank, DSHB; abd-A antibody from Santa Cruz Biotechnology) and incubated overnight in 4°C. Hearts were then washed with PBT three times for 15 minutes each, followed by incubation with fluorescent secondary antibodies (1:500, Jackson ImmunoResearch Laboratories, Inc.) and Alexa Fluor conjugated phalloidin (1:300, Life Technologies) in 4°C overnight. Hearts were then washed with PBT three times for 15 minutes each and then once with PBS. Hearts were mounted using ProLong Gold Mountant with DAPI (Life Technologies). Immunostained preparations were visualized with an Imager.Z1 equipped with an Apotome2 (Carl Zeiss, Jena), Hammamatsu Orca Flash4.0 camera, and ZEN imaging software (Carl Zeiss).

Live-imaging of the heart in drosophila pupae

For fluorescence-based heart function analysis, we crossed a fly line that contained both Hand4.2-GAL4 and a heart enhancer fused to tandem-Tomato fluorescent protein (tdtK), to controls, Nacα-RNAi, or bicaudal-RNAi flies [73]. White pupae (WP) from these crosses were collected and lined up on small petridishes with dorsal side facing up. Dishes were placed on a Zeiss Imager M1 equipped with a Hamamatsu Orca-Flash 4.0 Digital Camera (C11440), and heart images were captured every 2 minutes, for a duration of about 80 hours at room temperature (fluctuations of approx. 18–23°C) using ZEN imaging software (Carl Zeiss). Movies were formatted and compiled using ImageJ and iMovie (Apple).

Heart function analysis

Assessment of Drosophila heart function and structure using the Semi-automatic Optical Heartbeat Analysis (SOHA) method as previously described [74, 75]. Briefly, four-day old adult flies were anaesthetized with FlyNap (Carolina Biological Supply Co, Burlington, NC) and dissected in oxygenated artificial hemolymph to expose the beating heart within the abdomen. Hearts were placed on an Olympus BX61WI microscope while being filmed through a 10x water immersion lens with a high-speed digital camera (Hamamatsu Photonics C9300 digital camera) using HCI image capture software (Hamamatsu). High-speed movies were analyzed using the Semi-automated Optical Heartbeat Analysis (SOHA) software [74, 75]. Parameters measured include Heart Period (HP), Diastolic Interval (DI), Systolic Interval (SI), Arrhythmicity Index (AI), Diastolic Diameter (DD), Systolic Diameter (SD) and Fractional Shortening (FS) (Fig 2A). FS, a measure of contractility, is calculated using the following equation FS = (DD-SD)/DD.

Real-Time quantitative PCR

Approximately 25–30 hearts from early pupae (20-24hr APF) or adults were pooled for each biological sample. Three biological replicates were sampled for each condition. Total RNA was extracted using TRIzol (Invitrogen) and RNA (500 ng) was reverse transcribed to cDNA using QuantiTect Reverse Transcription Kit (Qiagen) and subject to qRT-PCR using the FastStart Essential DNA Green Master reagents (Roche) and LightCycler 96 Instrument (LC96, Roche). The data were analyzed using the ΔΔCt method using Ribosomal Protein 49 (Rp49) as a normalization control. Drosophila Nacα primer sequences: F- AAGGCCAGGAAGATCATGCT; R- ATCCTCGATCTTGGCCTCAC. Rp49 primer sequences: F-AAACGCGGTTCTGCATGAG R-GCCACCAGTCGGATCGATAT.

MCP cell culture, siRNA transfection, and Immunostaining

A pool of 4 unique siRNA sequences targeting different regions of selected genes and random control were obtained from the human siGENOME library from Dharmacon, Inc. Frozen 5-day old human MCPS [44, 76] were thawed and transfected with siRNAs at 5nM final concentration using Lipofectamine RNAiMAX transfection reagent (Invitrogen). Approximately 20,000 cells were plated in each well of a 384-well plate (Greiner Bio-One) coated with Matrigel Basement Membrane Matrix (Corning). Cells were incubated at 37°C and media refreshed every second day. Each experiment contained quadruplicate technical replicates per condition and performed on different batches of MCP clones programmed independently.

Immunostaining to identify cell-type composition of cultures were performed 9 days following siRNA transfection. Cells were fixed with warmed 4% paraformaldehyde solution for 30 minutes without agitation, followed by an additional 30 minutes of fixing with agitation. Wells were washed with Phosphate Buffered Saline (PBS) for 10 mins and repeated three times. Samples were then incubated with blocking solution for 30 mins (10% horse serum, 2.5% Triton-X-100, 10% gelatin). Primary antibodies were diluted in blocking solution and added to samples for 1 hour at room temperature (RT): ACTN1 (Sigma, A7811), TAGLN (Abcam, Ab14106), CDH5 (R&D Systems, AF938). Wells were washed with PBS for 15 mins and repeated three times. Samples were incubated with Alexa-conjugated secondary antibodies (Life Technologies) including DAPI diluted in blocking solution for 1 hour at RT. Wells were washed for 15 minutes and repeated three times, following which samples were imaged using a High-Throughput microscope (ImageXpress, Molecular Devices). Fluorescence was quantified using custom MetaXpress software (Molecular Devices) whereby, the number of total cells and cells positive for ACTN1, TAGLN, and CDH5 in each sample were quantified [44, 76].

Ethics statement

Sanford Burnham Prebys’ Medical Discovery Institute IRB Office’s reviewed the use of human derived Multipotent Progenitor Cells and determined that their use in research does not generate identifiable private information or identifiable biospecimens and thus does not involve human subjects.

Statistical analysis

Statistical analysis was performed using GraphPad Prism (GraphPad Software, La Jolla USA). Data are presented as the mean ± SEM. Human MCP, cardiomyocyte and fibroblast data were analyzed using a one-way ANOVA analysis followed by a Dunnett’s multiple comparison post-hoc test. A student’s unpaired t-test was used to analyze Drosophila heart function data.

Supporting information

S1 Fig. Cardiac phenotypes following Nacα and bicaudal knockdown.

A, Fluorescently tagged hearts using tdtK were imaged at higher magnification in vivo at white pupae stages which displayed intact hearts in control, Nacα-RNAi, and bicaudal-RNAi expressing hearts, suggesting that the heart histolyzes later, when remodeling during metamorphosis. Arrow heads point to the internal valves that separate the larval aorta from the heart. ^ point to the inflow tracts called ostia. B, Pupal dissections at approximately 24-26hr APF stained with phalloidin shows the presence of the fly aorta and heart in controls (left) and with Nacα KD (right) at two. magnifications. Arrowheads point to the presence of a heart tube.

(PDF)

S2 Fig. Nacα and bicaudal knockdown (KD) using additional RNAi lines.

KD of a second Nacα RNAi line (GD v36017) using Hand4.2-GAL4 driver, led to the presence of an adult heart tube. A, Hearts were dysfunctional, with significantly increased systolic diameter, that led to severely blunted Fractional Shortening. B, Phalloidin staining visualized highly disorganized circumferential fibers (arrowhead). C, KD of a second bicaudal RNAi line (GD v15453) using Hand4.2-GAL4 led to a no heart phenotype. *-indicates missing heart.

(PDF)

S3 Fig. Knockdown of Abd-B using heart specific driver Hand4.2-GAL4 led to intact hearts with posterior ends (indicated by arrowhead).

Posterior structures were more prominent and dilated compared to controls suggesting incomplete histolysis during cardiac remodeling.

(PDF)

S4 Fig. Wing blister phenotypes.

A, Wing hearts originate from pericardial cells and are required for wing maturation. In controls, proper wing heart function and hemolymph flow leads to adhesion of dorsal and ventral wing layers. B, Normal wing development is also observed with knockdown of Abd-B. C, Knockdown of Nacα using Hand4.2-GAL4 driver leads to fluid filled wing blisters (*) and crumpled wings (^). D, Co-Knockdown of Nacα and Abd-B did not rescue the wing blisters.

(PDF)

S5 Fig. The Hox gene abd-A does not rescue the cardiac phenotype induced by Nacα knockdown (KD).

A, Still images from video recording of hearts for SOHA analysis. While controls and abd-A KD retained a heart structure, Co-KD of Nacα and abd-A led to a no heart phenotype, indicating an inability for abd-A KD to rescue the loss of the heart caused by Nacα KD. B, Nacα KD led to reduced abd-A levels in the heart. *-indicates absence of heart structure. ^ indicates the presence of ostia structures.

(PDF)

S6 Fig. Nacα does not interact with DIAP1.

Overexpression of an inhibitor of apoptosis (Diap1). concurrently with Nacα -RNAi does not rescue the loss of the heart. * indicates absence of the adult heart tube.

(PDF)

S7 Fig. Nacα interactions with Abd-B to regulate heart function and structure.

Testing interaction of Nacα and Hox gene Abd-B using the cardiac specific tinHE-GAL4 driver by A, functional, B, temporal and C, structural assessment. A, Knockdown (KD) of Nacα (combined with UAS-Stinger::GFP to control for UAS binding sites) using tinHE-GAL4 caused a decrease in both diastolic and systolic diameters that produced a slight but not significant decrease in fractional shortening. KD of Abd-B (combined with UAS- Stinger::GFP) did not produce significant. changes in fractional shortening or diameters compared to control but fractional shortening and diastolic diameters were significantly higher compared to Nacα;Stinger genotype. Combined knockdown of Nacα and Abd-B produced heart parameters that were not different to controls but recapitulated heart function produced by Abd-B KD alone, suggesting that the heart function was rescued. B, Temporal parameters were unchanged with Nacα-RNAi expression. KD of Abd-B lengthened systolic interval compared to controls. Combined Nacα and Abd-B KD displayed longer systolic intervals similar to Abd-B KD alone, suggesting a rescue. C, Phalloidin staining of select genotypes. Compared to controls, Nacα knockdown disrupted circumferential fiber organization creating gaps in the matrix (similar to Fig 2I). KD of Abd-B did not significantly alter circumferential fiber organization. Combined knockdown of Nacα and Abd-B (2 examples shown) improved circumferential fiber organization compared to Nacα knockdown alone. * vs control KKGD. ^ compared to Nacα;Stinger. * p<0.05, ** p<0.01, *** p<0.001.

(PDF)

S8 Fig. Relative Nacα mRNA expression measured by Real-Time qPCR.

Nacα mRNA levels are reduced in adult hearts of HTT flies subject to Nacα KD during pupal stages only. Nacα mRNA levels are also reduced in early pupal hearts of HTT flies subject to Nacα KD during embryonic stages only.

(PDF)

S9 Fig. Nacα and Hox genes interact to redirect differentiation of Multipotent Cardiac Progenitors (MCPs).

A, Knockdown (KD) of Nacα, Hox genes or their combination did not produce a significant change in the proportion of endothelial cell (CDH5+). The KD of transcription factors Gata4/6,MyoCD increased the proportion of endothelial cells. B, Representative images of immunohistological staining for select conditions.

(PDF)

S10 Fig. Images of fluorescently labeled (tdtK) larval aorta and heart (abdominal segments 3 and 4) of White Pupae.

Heart tubes were present prior to cardiac remodeling with any of the SRP subunit knocked down using Hand4.2-GAL4, suggesting SRP subunits influence cardiac remodeling into adult structures during metamorphosis. Internal valves separating the larval aorta and heart are marked by arrowheads.

(PDF)

S1 Table. List of transgenic lines used in the study.

* indicates RNAi lines displayed in Figures. BDSC- Bloomington Drosophila Stock Center. VDRC- Vienna. Drosophila Resource Center.

(PDF)

S1 Video. In vivo imaging of cardiac remodeling during pupation in control flies.

RFP driven by a heart-specific enhancer (tdtk) was imaged throughout pupation every 2 mins starting at approximately 6–8 hour APF (After Puparium Formation). The larval aorta and heart were visualized by RFP signal during early pupation. As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As remodeling continued, RFP signal returned in the heart, and adult heart structures were evident, including wider heart diameters, formed ostia, and valves. Timestamps indicate APFs. Development of the heart may be slowed due to reduced ambient temperatures in the microscope room. See Fig 1 for still images from the video.

(MP4)

S2 Video. In vivo imaging of cardiac remodeling during pupation in Nacα knockdown flies.

RFP driven by a heart-specific enhancer (tdtk) was imaged throughout pupation every 2 mins starting at approximately 6–8 hour APF (After Puparium Formation). The larval aorta and heart were visualized by RFP signal during early pupation. As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As remodeling continued, RFP signal did not return, and no adult heart structures were evident, indicating complete lysis of the heart. Instead, the midline was filled in with rounded fat cells, similar to bic knockdown. Timestamps indicate APFs. Development of the heart may be slowed due to reduced ambient temperatures in the microscope room. See Fig 1 for still images from the video.

(MP4)

S3 Video. In vivo imaging of cardiac remodeling during pupation in bic knockdown flies.

RFP driven by a heart-specific enhancer (tdtk) was imaged throughout pupation every 2 mins starting at approximately 6–8 hour APF (After Puparium Formation). The larval aorta and heart were visualized by RFP signal during early pupation. As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As remodeling continued, RFP signal did not return, and no adult heart structures were evident, indicating complete lysis of the heart. Instead, the midline was filled in with rounded fat cells, similar to Nacα knockdown. Timestamps indicate APFs. Development of the heart may be slowed due to reduced ambient temperatures in the microscope room. See Fig 1 for still images from the video.

(MP4)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was funded by grants from the National Institutes of Health R01 HL054832 to RB and F32 HL131425-01 to AMS. Support also includes funding from The Department of Defense (W81XWH-21-1-0159) to AMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50–60. doi: 10.1038/nrcardio.2010.166 [DOI] [PubMed] [Google Scholar]
  • 2.Williams K, Carson J, Lo C. Genetics of Congenital Heart Disease. Biomolecules. 2019;9(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zaidi S, Brueckner M. Genetics and Genomics of Congenital Heart Disease. Circ Res. 2017;120(6):923–40. doi: 10.1161/CIRCRESAHA.116.309140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, et al. Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association. Circulation. 2018;138(21):e653–e711. doi: 10.1161/CIR.0000000000000606 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lage K, Greenway SC, Rosenfeld JA, Wakimoto H, Gorham JM, Segre AV, et al. Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proc Natl Acad Sci U S A. 2012;109(35):14035–40. doi: 10.1073/pnas.1210730109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. Recurrence of congenital heart defects in families. Circulation. 2009;120(4):295–301. doi: 10.1161/CIRCULATIONAHA.109.857987 [DOI] [PubMed] [Google Scholar]
  • 7.Theis JL, Vogler G, Missinato MA, Li X, Nielsen T, Zeng XI, et al. Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome. Elife. 2020;9. doi: 10.7554/eLife.59554 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Paige SL, Galdos FX, Lee S, Chin ET, Ranjbarvaziri S, Feyen DAM, et al. Patient-Specific Induced Pluripotent Stem Cells Implicate Intrinsic Impaired Contractility in Hypoplastic Left Heart Syndrome. Circulation. 2020;142(16):1605–8. doi: 10.1161/CIRCULATIONAHA.119.045317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schroeder AM, Allahyari M, Vogler G, Missinato MA, Nielsen T, Yu MS, et al. Model system identification of novel congenital heart disease gene candidates: focus on RPL13. Hum Mol Genet. 2019;28(23):3954–69. doi: 10.1093/hmg/ddz213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.van der Harst P, van Setten J, Verweij N, Vogler G, Franke L, Maurano MT, et al. 52 Genetic Loci Influencing Myocardial Mass. J Am Coll Cardiol. 2016;68(13):1435–48. doi: 10.1016/j.jacc.2016.07.729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Liu L, Wang HD, Cui CY, Qin YY, Fan TB, Peng BT, et al. Whole exome sequencing identifies novel mutation in eight Chinese children with isolated tetralogy of Fallot. Oncotarget. 2017;8(63):106976–88. doi: 10.18632/oncotarget.22202 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wang S, Sakai H, Wiedmann M. NAC covers ribosome-associated nascent chains thereby forming a protective environment for regions of nascent chains just emerging from the peptidyl transferase center. J Cell Biol. 1995;130(3):519–28. doi: 10.1083/jcb.130.3.519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.George R, Beddoe T, Landl K, Lithgow T. The yeast nascent polypeptide-associated complex initiates protein targeting to mitochondria in vivo. Proc Natl Acad Sci U S A. 1998;95(5):2296–301. doi: 10.1073/pnas.95.5.2296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.George R, Walsh P, Beddoe T, Lithgow T. The nascent polypeptide-associated complex (NAC) promotes interaction of ribosomes with the mitochondrial surface in vivo. FEBS Lett. 2002;516(1–3):213–6. doi: 10.1016/s0014-5793(02)02528-0 [DOI] [PubMed] [Google Scholar]
  • 15.Funfschilling U, Rospert S. Nascent polypeptide-associated complex stimulates protein import into yeast mitochondria. Mol Biol Cell. 1999;10(10):3289–99. doi: 10.1091/mbc.10.10.3289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hsieh HH, Lee JH, Chandrasekar S, Shan SO. A ribosome-associated chaperone enables substrate triage in a cotranslational protein targeting complex. Nat Commun. 2020;11(1):5840. doi: 10.1038/s41467-020-19548-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Saraogi I, Shan SO. Molecular mechanism of co-translational protein targeting by the signal recognition particle. Traffic. 2011;12(5):535–42. doi: 10.1111/j.1600-0854.2011.01171.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang Y, Berndt U, Golz H, Tais A, Oellerer S, Wolfle T, et al. NAC functions as a modulator of SRP during the early steps of protein targeting to the endoplasmic reticulum. Mol Biol Cell. 2012;23(16):3027–40. doi: 10.1091/mbc.E12-02-0112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Braat AK, Yan N, Arn E, Harrison D, Macdonald PM. Localization-dependent oskar protein accumulation; control after the initiation of translation. Dev Cell. 2004;7(1):125–31. doi: 10.1016/j.devcel.2004.06.009 [DOI] [PubMed] [Google Scholar]
  • 20.Markesich DC, Gajewski KM, Nazimiec ME, Beckingham K. bicaudal encodes the Drosophila beta NAC homolog, a component of the ribosomal translational machinery*. Development. 2000;127(3):559–72. doi: 10.1242/dev.127.3.559 [DOI] [PubMed] [Google Scholar]
  • 21.Smith JL, Wilson JE, Macdonald PM. Overexpression of oskar directs ectopic activation of nanos and presumptive pole cell formation in Drosophila embryos. Cell. 1992;70(5):849–59. doi: 10.1016/0092-8674(92)90318-7 [DOI] [PubMed] [Google Scholar]
  • 22.Ephrussi A, Lehmann R. Induction of germ cell formation by oskar. Nature. 1992;358(6385):387–92. doi: 10.1038/358387a0 [DOI] [PubMed] [Google Scholar]
  • 23.St-Arnaud R, Quelo I. Transcriptional coactivators potentiating AP-1 function in bone. Front Biosci. 1998;3:d838–48. doi: 10.2741/a327 [DOI] [PubMed] [Google Scholar]
  • 24.Moreau A, Yotov WV, Glorieux FH, St-Arnaud R. Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol Cell Biol. 1998;18(3):1312–21. doi: 10.1128/MCB.18.3.1312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hekmatnejad B, Mandic V, Yu VW, Akhouayri O, Arabian A, St-Arnaud R. Altered gene dosage confirms the genetic interaction between FIAT and alphaNAC. Gene. 2014;538(2):328–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Murayama E, Sarris M, Redd M, Le Guyader D, Vivier C, Horsley W, et al. NACA deficiency reveals the crucial role of somite-derived stromal cells in haematopoietic niche formation. Nat Commun. 2015;6:8375. doi: 10.1038/ncomms9375 [DOI] [PubMed] [Google Scholar]
  • 27.Li H, Randall WR, Du SJ. skNAC (skeletal Naca), a muscle-specific isoform of Naca (nascent polypeptide-associated complex alpha), is required for myofibril organization. FASEB J. 2009;23(6):1988–2000. doi: 10.1096/fj.08-125542 [DOI] [PubMed] [Google Scholar]
  • 28.Berger F, Berkholz J, Breustedt T, Ploen D, Munz B. Skeletal muscle-specific variant of nascent polypeptide associated complex alpha (skNAC): implications for a specific role in mammalian myoblast differentiation. Eur J Cell Biol. 2012;91(2):150–5. doi: 10.1016/j.ejcb.2011.10.004 [DOI] [PubMed] [Google Scholar]
  • 29.Berkholz J, Orgeur M, Stricker S, Munz B. skNAC and Smyd1 in transcriptional control. Exp Cell Res. 2015;336(2):182–91. doi: 10.1016/j.yexcr.2015.06.019 [DOI] [PubMed] [Google Scholar]
  • 30.Berkholz J, Michalick L, Munz B. The E3 SUMO ligase Nse2 regulates sumoylation and nuclear-to-cytoplasmic translocation of skNAC-Smyd1 in myogenesis. J Cell Sci. 2014;127(Pt 17):3794–804. doi: 10.1242/jcs.150334 [DOI] [PubMed] [Google Scholar]
  • 31.Park CY, Pierce SA, von Drehle M, Ivey KN, Morgan JA, Blau HM, et al. skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration. Proc Natl Acad Sci U S A. 2010;107(48):20750–5. doi: 10.1073/pnas.1013493107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sims RJ, 3rd, Weihe EK, Zhu L, O’Malley S, Harriss JV, Gottlieb PD. m-Bop, a repressor protein essential for cardiogenesis, interacts with skNAC, a heart- and muscle-specific transcription factor. J Biol Chem. 2002;277(29):26524–9. doi: 10.1074/jbc.M204121200 [DOI] [PubMed] [Google Scholar]
  • 33.Han Z, Yi P, Li X, Olson EN. Hand, an evolutionarily conserved bHLH transcription factor required for Drosophila cardiogenesis and hematopoiesis. Development. 2006;133(6):1175–82. doi: 10.1242/dev.02285 [DOI] [PubMed] [Google Scholar]
  • 34.Kimbrell DA, Hice C, Bolduc C, Kleinhesselink K, Beckingham K. The Dorothy enhancer has Tinman binding sites and drives hopscotch-induced tumor formation. Genesis. 2002;34(1–2):23–8. doi: 10.1002/gene.10134 [DOI] [PubMed] [Google Scholar]
  • 35.Ponzielli R, Astier M, Chartier A, Gallet A, Therond P, Semeriva M. Heart tube patterning in Drosophila requires integration of axial and segmental information provided by the Bithorax Complex genes and hedgehog signaling. Development. 2002;129(19):4509–21. doi: 10.1242/dev.129.19.4509 [DOI] [PubMed] [Google Scholar]
  • 36.Lo PC, Frasch M. Establishing A-P polarity in the embryonic heart tube: a conserved function of Hox genes in Drosophila and vertebrates? Trends Cardiovasc Med. 2003;13(5):182–7. doi: 10.1016/s1050-1738(03)00074-4 [DOI] [PubMed] [Google Scholar]
  • 37.Lo PC, Skeath JB, Gajewski K, Schulz RA, Frasch M. Homeotic genes autonomously specify the anteroposterior subdivision of the Drosophila dorsal vessel into aorta and heart. Dev Biol. 2002;251(2):307–19. doi: 10.1006/dbio.2002.0839 [DOI] [PubMed] [Google Scholar]
  • 38.Monier B, Astier M, Semeriva M, Perrin L. Steroid-dependent modification of Hox function drives myocyte reprogramming in the Drosophila heart. Development. 2005;132(23):5283–93. doi: 10.1242/dev.02091 [DOI] [PubMed] [Google Scholar]
  • 39.Lovato TL, Nguyen TP, Molina MR, Cripps RM. The Hox gene abdominal-A specifies heart cell fate in the Drosophila dorsal vessel. Development. 2002;129(21):5019–27. doi: 10.1242/dev.129.21.5019 [DOI] [PubMed] [Google Scholar]
  • 40.McGuire SE, Le PT, Osborn AJ, Matsumoto K, Davis RL. Spatiotemporal rescue of memory dysfunction in Drosophila. Science. 2003;302(5651):1765–8. doi: 10.1126/science.1089035 [DOI] [PubMed] [Google Scholar]
  • 41.Gamerdinger M, Hanebuth MA, Frickey T, Deuerling E. The principle of antagonism ensures protein targeting specificity at the endoplasmic reticulum. Science. 2015;348(6231):201–7. doi: 10.1126/science.aaa5335 [DOI] [PubMed] [Google Scholar]
  • 42.Kirstein-Miles J, Scior A, Deuerling E, Morimoto RI. The nascent polypeptide-associated complex is a key regulator of proteostasis. EMBO J. 2013;32(10):1451–68. doi: 10.1038/emboj.2013.87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Arsenovic PT, Maldonado AT, Colleluori VD, Bloss TA. Depletion of the C. elegans NAC engages the unfolded protein response, resulting in increased chaperone expression and apoptosis. PLoS One. 2012;7(9):e44038. doi: 10.1371/journal.pone.0044038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cunningham TJ, Yu MS, McKeithan WL, Spiering S, Carrette F, Huang CT, et al. Id genes are essential for early heart formation. Genes Dev. 2017;31(13):1325–38. doi: 10.1101/gad.300400.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pikkarainen S, Tokola H, Kerkela R, Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc Res. 2004;63(2):196–207. doi: 10.1016/j.cardiores.2004.03.025 [DOI] [PubMed] [Google Scholar]
  • 46.Pipes GC, Creemers EE, Olson EN. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006;20(12):1545–56. doi: 10.1101/gad.1428006 [DOI] [PubMed] [Google Scholar]
  • 47.Akopian D, Shen K, Zhang X, Shan SO. Signal recognition particle: an essential protein-targeting machine. Annu Rev Biochem. 2013;82:693–721. doi: 10.1146/annurev-biochem-072711-164732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Mercier E, Holtkamp W, Rodnina MV, Wintermeyer W. Signal recognition particle binds to translating ribosomes before emergence of a signal anchor sequence. Nucleic Acids Res. 2017;45(20):11858–66. doi: 10.1093/nar/gkx888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Schibich D, Gloge F, Pohner I, Bjorkholm P, Wade RC, von Heijne G, et al. Global profiling of SRP interaction with nascent polypeptides. Nature. 2016;536(7615):219–23. doi: 10.1038/nature19070 [DOI] [PubMed] [Google Scholar]
  • 50.Armistead J, Triggs-Raine B. Diverse diseases from a ubiquitous process: the ribosomopathy paradox. FEBS Lett. 2014;588(9):1491–500. doi: 10.1016/j.febslet.2014.03.024 [DOI] [PubMed] [Google Scholar]
  • 51.Long PA, Theis JL, Shih YH, Maleszewski JJ, Abell Aleff PC, Evans JM, et al. Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy. Hum Mol Genet. 2017;26(15):2874–81. doi: 10.1093/hmg/ddx169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ward T, Tai W, Morton S, Impens F, Van Damme P, Van Haver D, et al. Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency. Circ Res. 2021;128(8):1156–69. doi: 10.1161/CIRCRESAHA.120.316966 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kondrashov N, Pusic A, Stumpf CR, Shimizu K, Hsieh AC, Ishijima J, et al. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell. 2011;145(3):383–97. doi: 10.1016/j.cell.2011.03.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Shi Z, Fujii K, Kovary KM, Genuth NR, Rost HL, Teruel MN, et al. Heterogeneous Ribosomes Preferentially Translate Distinct Subpools of mRNAs Genome-wide. Mol Cell. 2017;67(1):71–+. doi: 10.1016/j.molcel.2017.05.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J Pediatr. 2008;153(6):807–13. doi: 10.1016/j.jpeds.2008.05.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Vlachos A, Osorio DS, Atsidaftos E, Kang J, Lababidi ML, Seiden HS, et al. Increased Prevalence of Congenital Heart Disease in Children With Diamond Blackfan Anemia Suggests Unrecognized Diamond Blackfan Anemia as a Cause of Congenital Heart Disease in the General Population: A Report of the Diamond Blackfan Anemia Registry. Circ Genom Precis Med. 2018;11(5):e002044. doi: 10.1161/CIRCGENETICS.117.002044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017;49(11):1593–601. doi: 10.1038/ng.3970 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Bezzerri V, Cipolli M. Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives. Mol Diagn Ther. 2019;23(2):281–90. doi: 10.1007/s40291-018-0368-2 [DOI] [PubMed] [Google Scholar]
  • 59.Hauet Q, Beaupain B, Micheau M, Blayo M, Gandemer V, Gottrand F, et al. Cardiomyopathies and congenital heart diseases in Shwachman-Diamond syndrome: a national survey. Int J Cardiol. 2013;167(3):1048–50. doi: 10.1016/j.ijcard.2012.10.084 [DOI] [PubMed] [Google Scholar]
  • 60.Hoang TT, Goldmuntz E, Roberts AE, Chung WK, Kline JK, Deanfield JE, et al. The Congenital Heart Disease Genetic Network Study: Cohort description. PLoS One. 2018;13(1):e0191319. doi: 10.1371/journal.pone.0191319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Roux M, Zaffran S. Hox Genes in Cardiovascular Development and Diseases. J Dev Biol. 2016;4(2). doi: 10.3390/jdb4020014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Maliken BD, Kanisicak O, Karch J, Khalil H, Fu X, Boyer JG, et al. Gata4-Dependent Differentiation of c-Kit(+)-Derived Endothelial Cells Underlies Artefactual Cardiomyocyte Regeneration in the Heart. Circulation. 2018;138(10):1012–24. doi: 10.1161/CIRCULATIONAHA.118.033703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Masino AM, Gallardo TD, Wilcox CA, Olson EN, Williams RS, Garry DJ. Transcriptional regulation of cardiac progenitor cell populations. Circ Res. 2004;95(4):389–97. doi: 10.1161/01.RES.0000138302.02691.be [DOI] [PubMed] [Google Scholar]
  • 64.Bertrand N, Roux M, Ryckebusch L, Niederreither K, Dolle P, Moon A, et al. Hox genes define distinct progenitor sub-domains within the second heart field. Dev Biol. 2011;353(2):266–74. doi: 10.1016/j.ydbio.2011.02.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Stefanovic S, Laforest B, Desvignes JP, Lescroart F, Argiro L, Maurel-Zaffran C, et al. Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation. Elife. 2020;9. doi: 10.7554/eLife.55124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Zeitouni B, Senatore S, Severac D, Aknin C, Semeriva M, Perrin L. Signalling pathways involved in adult heart formation revealed by gene expression profiling in Drosophila. PLoS Genet. 2007;3(10):1907–21. doi: 10.1371/journal.pgen.0030174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118(2):401–15. doi: 10.1242/dev.118.2.401 [DOI] [PubMed] [Google Scholar]
  • 68.Hallier B, Hoffmann J, Roeder T, Togel M, Meyer H, Paululat A. The bHLH Transcription Factor Hand Regulates the Expression of Genes Critical to Heart and Muscle Function in Drosophila melanogaster. PLoS One. 2015;10(8):e0134204. doi: 10.1371/journal.pone.0134204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Togel M, Meyer H, Lehmacher C, Heinisch JJ, Pass G, Paululat A. The bHLH transcription factor hand is required for proper wing heart formation in Drosophila. Dev Biol. 2013;381(2):446–59. doi: 10.1016/j.ydbio.2013.05.027 [DOI] [PubMed] [Google Scholar]
  • 70.Lo PC, Frasch M. A role for the COUP-TF-related gene seven-up in the diversification of cardioblast identities in the dorsal vessel of Drosophila. Mech Dev. 2001;104(1–2):49–60. doi: 10.1016/s0925-4773(01)00361-6 [DOI] [PubMed] [Google Scholar]
  • 71.Yin Z, Xu XL, Frasch M. Regulation of the twist target gene tinman by modular cis-regulatory elements during early mesoderm development. Development. 1997;124(24):4971–82. doi: 10.1242/dev.124.24.4971 [DOI] [PubMed] [Google Scholar]
  • 72.Wessells RJ, Fitzgerald E, Cypser JR, Tatar M, Bodmer R. Insulin regulation of heart function in aging fruit flies. Nat Genet. 2004;36(12):1275–81. doi: 10.1038/ng1476 [DOI] [PubMed] [Google Scholar]
  • 73.Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M, et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature. 2007;448(7150):151–6. doi: 10.1038/nature05954 [DOI] [PubMed] [Google Scholar]
  • 74.Fink M, Callol-Massot C, Chu A, Ruiz-Lozano P, Izpisua Belmonte JC, Giles W, et al. A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts. BioTechniques. 2009;46(2):101–13. doi: 10.2144/000113078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Ocorr K, Fink M, Cammarato A, Bernstein S, Bodmer R. Semi-automated Optical Heartbeat Analysis of small hearts. J Vis Exp. 2009(31). doi: 10.3791/1435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Yu MS, Spiering S, Colas AR. Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells. J Vis Exp. 2018(136). doi: 10.3791/57688 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Pablo Wappner, Scott M Williams

12 Apr 2022

Dear Dr Schroeder ,

Thank you very much for submitting your Research Article entitled 'Nascent Polypeptide Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Pablo Wappner

Associate Editor

PLOS Genetics

Scott Williams

Section Editor: Human Variation

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The manuscript from Schroeder et al describes a novel role for the protein biogenesis cofactors Nascent polypeptide-Associated Complex (NAC) in fly and human iPSCs cardiac differentiation and morphogenesis. The authors show that knockdown (KD) of the alpha-subunit of NAC in the developing fly heart disrupts cardiac morphogenesis. KD of Naca or Nacb results in a fly with no heart. Indeed, Naca KD using specific cardiac GAL4 driver led to histolysis of the heart during metamorphosis. Temporal reduction of Naca expression during different developmental stages suggests that Naca is primarily requires developmentally for establishing a normal heart in adult, rather than maintaining its function in ages. They then identify that reduction of NACA in human iPSC-derived multipotent cardiac progenitors reduces the proportion of cardiomyocytes, whereas proportion of fibroblast is increased. To better understand the mechanisms driving complete histolysis of the heart during larval/pupal metamorphosis, the authors examine the expression of Hox gene Abd-B as this gene is normally expressed in the posterior larval heart region destined for histolysis. They show that Abd-B is misexpressed in KD Naca and that heart loss can be rescued by combined KD of Naca and Abd-B. Consistently, combined KD of NACA and HOXC12 or HOXD12 (Abd-B homologs) reverses the proportion of cardiomyocyte and fibroblast populations observed in KD NACA human iPSC-derived cells experiments.

In general, the study is well executed. The major scientific concern is that while the authors propose that reduction of Naca/NACA leads to misexpression of Abd-A/HOXC12 in cardiac cells, the molecular mechanism leading to this abnormal regulation remains unclear. The use of a cardiac specific Gal4 driver in fly to KD Naca only in the forming heart provides some support for the link between Naca and Abd-B during development, but there is no data confirming the specificity of this link in other cell types. It is easy to address with another drivers in order to understand if it is a generic or tissue specific function of Naca.

Data with tinC�4-Gal4 suggest that expression thresholds of Naca is required in cardiac cells. However, the authors did not address this point by quantifying Naca expression.

KD of Naca in the heart led to ectopic expression of Abd-A within the cell. The authors should discuss this point in term of sequence conservation. In the same perspective the authors should discuss the specificity of Naca on Abd-A and not other Hox genes.

Does temporal requirement of Naca is only associated with Abd-A misexpression?

The authors used cardiomyocytes derived from human iPSCs to determine whether similar role of NACA could be observed in other model system. It is clear that NACA siRNA inhibits CM differentiation, but the authors should convince the reader that progenitor cells are not blocked in their initial state.

siRNA against HOXC12 and HOXD12 can reverse the effect of siRNA NACA in the iPSC model. What is the specificity of this effect? Quantification of HOXC12 and HOXD12 in treated iPSCs should be evaluated too.

Temporal differentiation of iPSC to CM/fibroblasts should be also determine since premature differentiation of cardiac progenitors has been reported in Hoxb1 mutant mice.

Reviewer #2: The manuscript by Schroeder et al presents an investigation of the role of the nascent polypeptide associated complex (Nac) and, secondarily, the signal recognition particle (SRP) in cardiac development. Evidence from human genetics and previous work in Drosophila suggests a role for NACA, which encodes one of the two Nac subunits, in congenital heart disease. To investigate this further, Schroeder et al expressed shRNAs targeting each Nac subunit, Nac-alpha and bicaudal, and found that these were required for heart development. They extended this finding in two interesting ways. First they investigated the effects of Nac knockdown on Hox gene expression. In normal development, the larval heart region that is destined for histolysis during pupal development expresses Abd-B, while the larval aorta which remodels to become the adult heart expresses Ubx. They demonstrate that Nac-alpha knockdown produces ectopic expression of Abd-B, and histolysis of the entire heart in early pupal stages, and furthermore that heart development could be restored to the Nac-alpha knockdown by also knocking down Abd-B. Secondly, using the GAL4-GAL80ts system they demonstrate a specific temporal requirement for Nac-alpha activity during embryonic and pupal stages.

I found this part of the manuscript to be convincing, with only minor concerns that I will outline below.

The authors next investigate, by treating human iPSCs with siRNAs, whether the same regulatory interaction between Nac-alpha and Hox genes is involved in cardiomyocyte differentiation. There are two apparent Abd-B orthologues in humans, HOXC12 and HOXD12. In these cells, knockdown of Nac-alpha reduces the proportion of cardiomyocytes and increases that of fibroblasts. Knockdown of either HOXC12 or HOXD12 on their own had little effect. In combination with Nac-alpha knockdown, knockdown of either HOXC12, HOXD12, or both, partially rescued the effects of Nac-alpha knockdown to roughly equivalent extents.

For me, this result is weak because the double knockdown of HOXC12 and HOXD12 is not examined on its own. It is possible that these genes have redundant functions and the double knockdown would affect the proportions of the various cell types. Also, to further examine whether the regulatory pathway in flies is conserved in humans, the effects of overexpression of HOXC12/HOXD12 should be examined.

The final figure examines the effects of disrupting SRP components on cardiac development. This is of interest because SRP, like Nac, is also recruited to nascent polypeptides. The authors demonstrate that knockdown of various SRP subunits produces a variety of phenotypes, but these results are not extended to the level of any mechanistic insights.

Further comments and concerns:

Fig 1D-F: I find it very hard to see the described larval heart phenotypes in these panels. The data are more convincing in Fig S1A. The authors should consider improving the imaging in Fig 1 or substituting the data in Fig S1 to demonstrate the existence of larval hearts in all genotypes.

Fig S2: The nature of the control should be provided.

Discussion: This is very long and poorly organized, moving from flies to humans to mice, then back to flies, etc. I think it could be reduced by 50% without substantial loss. The paragraph starting with line 476 includes a fair bit of reiteration of results, the paragraph starting with line 492 could be deleted, and the two paragraphs that discuss Figure 6 are speculative and go far beyond the supporting experimental data. Finally, the presentation of the role of the Nac complex in embryonic patterning in the introduction and discussion contains inaccuracies. Nac is implicated in RNA localization which in turn is required for oskar and nanos translation, so it is not necessarily the case that its effects are only at the level of translation. Relevant to lines 465-468, Oskar protein begins to accumulate at the posterior pole already during mid-oogenesis, not just in the syncytial embryo as this discussion implies.

Reviewer #3: In this manuscript the authors investigate the role of Nascent polypeptide-Associated Complex (NAC) and Signal-Recognition-Particle (SRP) during heart development of Drosophila. Interestingly the authors suggest a patterning role for NAC and SRP rather than a general translational regulation role for these two important complexes.

Their data show that two NAC subunits (Nac-alpha and bicaudal/Nac-beta) are needed for normal heart remodelling during pupal stages. The heart is present at early pupal stages but lost during remodelling in the pupa upon Nac-alpha or bic knock-down. Interestingly this phenotype is rescued by double knock-down of Nac-alpha and the Hox gene AbdB. The latter becomes ectopically expressed upon NAC knock-down. The authors show that absence of AbdB is normally needed for effective heart remodelling from the larval to the adult heart during pupal stages.

From temperature shift experiments the authors hypothesise that Nac-alpha is needed to ‘pre-program’ cardiomyocytes already in the embryo for their later remodelling during the pupal stage. How this pre-programming should occur remains mysterious.

Additionally, the authors investigate a role of SRP subunits and find phenotypes that suggest some spatially restricted function of SRP during heart development in certain segments.

While I find the manuscript overall interesting, I have a number of suggestions that should be addressed by the authors during revisions to substantiate or tone-down some of the major conclusions.

Important points:

1. RNAi specificity and genotypes. Importantly, the authors use two independent RNAi lines to knock-down Nac-alpha and bic, at least according to the methods. However, Figures 1 and 2 show only the phenotype of one of each without specifying which one was used. Please add the exact genotypes in the figure legend and provide the second RNAi line phenotype in the same figure or in the supplemental figure (at least for Figure 1).

2. The fact that mis-expression of AbdB in developing pupal hearts is induced as a consequence of NAC knock-down is really interesting. However, it is hard to see on the current image in Figure 3E. Please provide separate grey channel images for the AbdB and the DAPI stains in control and RNAi that we can appreciate the signal in the nuclei.

3. The authors put forward the interesting idea that NAC is needed specifically in the embryo to prime the heart for later remodelling. This argument largely rests on the finding that knock-down of Nac-alpha during pupal stages only does not result in a strong phenotype. However, it is a well-known phenomenon that knock-down by RNAi depends on the driver used and takes time to be complete. Hence, only knocking-down at pupal stages might simple not reduce the proteins levels of Nac-alpha enough to produce a phenotype. This is consistent with the finding of the authors that the strongest phenotype is found when Nac-alpha is continuously knocked-down or knocked-down in the embryo and in pupae. Thus, the authors may want to explore additional routes to back up their conclusion on this important point. Otherwise, the strength of the phenotype may simply correlate with proteins levels during the remodelling stage.

Possibilities would be to use an antibody against Nac-alpha to show its absence in remodelling pupal hearts following knock-down in pupa only, in contrast to its potential presence in pupae when knocked-down the first 24h or 48h of development only.

Alternatives could be using a protein degradation system such us deGradeFP.

4. Figure 5 is missing a control for effectiveness of NACA RNAi when combined with a second siRNA against an unrelated gene. Any of the combinations shown at the moment appear to rescue, even though this rescue is not very obvious in the overview images. Would higher magnifications help?

5. Can the different phenotypes seen after knock-down of the various SRP subunits not simply be explained by varying effectiveness of knock-down? Again, no second RNAi lines are shown and no protein amounts were measured, hence the shown phenotypes are very hard to interpret. In my opinion, it would take a significant amount of more work to support the hypothesis of the authors that the different SRP subunits do different things in the different heart cells. Properly investigating this hypothesis will take an entire manuscript on its own. How is the phenotype when the same RNAi lines were used in skeletal muscle cells?

6. The discussion is overly long.

Minor points.

1. The heart remodelling movies are really nice. Please include a time stamp in the movies. Compression of the 70MB large movie files would be useful.

2. Figure 2C and F, please shift the driver labels a bit to the left or change the organisation of the labels. Hard to grasp which RNAi was combined with which driver in which of the graphs. Please label micro with µ. What is a KK control? An unrelated RNAi line? Were no GD lines used?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Stéphane Zaffran

Reviewer #2: Yes: Paul Lasko

Reviewer #3: No

Decision Letter 1

Pablo Wappner, Scott M Williams

27 Sep 2022

Dear Dr  Schroeder,

We are pleased to inform you that your manuscript entitled "Nascent Polypeptide Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Pablo Wappner

Academic Editor

PLOS Genetics

Scott Williams

Section Editor

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The manuscript from Schroeder et al. has been well revised. The authors have completed significant revisions based on my comments. I find the current version of the manuscript considerably improved. The authors have replied to my main concern regarding the tissue specificity of Naca and Abd-B in the heart. The authors used several Gal4 lines to KD Naca in different cell types including pericardial cells. These novel data provide additional support for a tissue-specific effect of Naca KD in the heart. As requested, the authors have measured Naca mRNA levels at different stages of development, however they did decide to include the Naca expression data only in pupae and in newly eclosed adult hearts in the revision. In addition to Abd-B, the authors have included data examining the Hox gene abd-A. Based on their results the authors conclude that there is specificity in interaction between Naca and Hox genes. Cardiomyocytes derived from human iPSCs was used as human model. As requested, the authors used differentiation markers to show that cells are not stuck in a progenitor state. Quantification of HOXC12 and HOXD12 alone are included in the revision. The current version included a shorten discussion. Therefore, the authors have satisfactorily answered all my questions.

Reviewer #3: The authors have addressed all my initial suggestions in a very satisfactory way. I recommend publication of this interesting and well presented manuscript.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-22-00273R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Pablo Wappner, Scott M Williams

11 Oct 2022

PGENETICS-D-22-00273R1

Nascent polypeptide-Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling

Dear Dr Schroeder,

We are pleased to inform you that your manuscript entitled "Nascent polypeptide-Associated Complex and Signal Recognition Particle have cardiac-specific roles in heart development and remodeling" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Cardiac phenotypes following Nacα and bicaudal knockdown.

    A, Fluorescently tagged hearts using tdtK were imaged at higher magnification in vivo at white pupae stages which displayed intact hearts in control, Nacα-RNAi, and bicaudal-RNAi expressing hearts, suggesting that the heart histolyzes later, when remodeling during metamorphosis. Arrow heads point to the internal valves that separate the larval aorta from the heart. ^ point to the inflow tracts called ostia. B, Pupal dissections at approximately 24-26hr APF stained with phalloidin shows the presence of the fly aorta and heart in controls (left) and with Nacα KD (right) at two. magnifications. Arrowheads point to the presence of a heart tube.

    (PDF)

    S2 Fig. Nacα and bicaudal knockdown (KD) using additional RNAi lines.

    KD of a second Nacα RNAi line (GD v36017) using Hand4.2-GAL4 driver, led to the presence of an adult heart tube. A, Hearts were dysfunctional, with significantly increased systolic diameter, that led to severely blunted Fractional Shortening. B, Phalloidin staining visualized highly disorganized circumferential fibers (arrowhead). C, KD of a second bicaudal RNAi line (GD v15453) using Hand4.2-GAL4 led to a no heart phenotype. *-indicates missing heart.

    (PDF)

    S3 Fig. Knockdown of Abd-B using heart specific driver Hand4.2-GAL4 led to intact hearts with posterior ends (indicated by arrowhead).

    Posterior structures were more prominent and dilated compared to controls suggesting incomplete histolysis during cardiac remodeling.

    (PDF)

    S4 Fig. Wing blister phenotypes.

    A, Wing hearts originate from pericardial cells and are required for wing maturation. In controls, proper wing heart function and hemolymph flow leads to adhesion of dorsal and ventral wing layers. B, Normal wing development is also observed with knockdown of Abd-B. C, Knockdown of Nacα using Hand4.2-GAL4 driver leads to fluid filled wing blisters (*) and crumpled wings (^). D, Co-Knockdown of Nacα and Abd-B did not rescue the wing blisters.

    (PDF)

    S5 Fig. The Hox gene abd-A does not rescue the cardiac phenotype induced by Nacα knockdown (KD).

    A, Still images from video recording of hearts for SOHA analysis. While controls and abd-A KD retained a heart structure, Co-KD of Nacα and abd-A led to a no heart phenotype, indicating an inability for abd-A KD to rescue the loss of the heart caused by Nacα KD. B, Nacα KD led to reduced abd-A levels in the heart. *-indicates absence of heart structure. ^ indicates the presence of ostia structures.

    (PDF)

    S6 Fig. Nacα does not interact with DIAP1.

    Overexpression of an inhibitor of apoptosis (Diap1). concurrently with Nacα -RNAi does not rescue the loss of the heart. * indicates absence of the adult heart tube.

    (PDF)

    S7 Fig. Nacα interactions with Abd-B to regulate heart function and structure.

    Testing interaction of Nacα and Hox gene Abd-B using the cardiac specific tinHE-GAL4 driver by A, functional, B, temporal and C, structural assessment. A, Knockdown (KD) of Nacα (combined with UAS-Stinger::GFP to control for UAS binding sites) using tinHE-GAL4 caused a decrease in both diastolic and systolic diameters that produced a slight but not significant decrease in fractional shortening. KD of Abd-B (combined with UAS- Stinger::GFP) did not produce significant. changes in fractional shortening or diameters compared to control but fractional shortening and diastolic diameters were significantly higher compared to Nacα;Stinger genotype. Combined knockdown of Nacα and Abd-B produced heart parameters that were not different to controls but recapitulated heart function produced by Abd-B KD alone, suggesting that the heart function was rescued. B, Temporal parameters were unchanged with Nacα-RNAi expression. KD of Abd-B lengthened systolic interval compared to controls. Combined Nacα and Abd-B KD displayed longer systolic intervals similar to Abd-B KD alone, suggesting a rescue. C, Phalloidin staining of select genotypes. Compared to controls, Nacα knockdown disrupted circumferential fiber organization creating gaps in the matrix (similar to Fig 2I). KD of Abd-B did not significantly alter circumferential fiber organization. Combined knockdown of Nacα and Abd-B (2 examples shown) improved circumferential fiber organization compared to Nacα knockdown alone. * vs control KKGD. ^ compared to Nacα;Stinger. * p<0.05, ** p<0.01, *** p<0.001.

    (PDF)

    S8 Fig. Relative Nacα mRNA expression measured by Real-Time qPCR.

    Nacα mRNA levels are reduced in adult hearts of HTT flies subject to Nacα KD during pupal stages only. Nacα mRNA levels are also reduced in early pupal hearts of HTT flies subject to Nacα KD during embryonic stages only.

    (PDF)

    S9 Fig. Nacα and Hox genes interact to redirect differentiation of Multipotent Cardiac Progenitors (MCPs).

    A, Knockdown (KD) of Nacα, Hox genes or their combination did not produce a significant change in the proportion of endothelial cell (CDH5+). The KD of transcription factors Gata4/6,MyoCD increased the proportion of endothelial cells. B, Representative images of immunohistological staining for select conditions.

    (PDF)

    S10 Fig. Images of fluorescently labeled (tdtK) larval aorta and heart (abdominal segments 3 and 4) of White Pupae.

    Heart tubes were present prior to cardiac remodeling with any of the SRP subunit knocked down using Hand4.2-GAL4, suggesting SRP subunits influence cardiac remodeling into adult structures during metamorphosis. Internal valves separating the larval aorta and heart are marked by arrowheads.

    (PDF)

    S1 Table. List of transgenic lines used in the study.

    * indicates RNAi lines displayed in Figures. BDSC- Bloomington Drosophila Stock Center. VDRC- Vienna. Drosophila Resource Center.

    (PDF)

    S1 Video. In vivo imaging of cardiac remodeling during pupation in control flies.

    RFP driven by a heart-specific enhancer (tdtk) was imaged throughout pupation every 2 mins starting at approximately 6–8 hour APF (After Puparium Formation). The larval aorta and heart were visualized by RFP signal during early pupation. As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As remodeling continued, RFP signal returned in the heart, and adult heart structures were evident, including wider heart diameters, formed ostia, and valves. Timestamps indicate APFs. Development of the heart may be slowed due to reduced ambient temperatures in the microscope room. See Fig 1 for still images from the video.

    (MP4)

    S2 Video. In vivo imaging of cardiac remodeling during pupation in Nacα knockdown flies.

    RFP driven by a heart-specific enhancer (tdtk) was imaged throughout pupation every 2 mins starting at approximately 6–8 hour APF (After Puparium Formation). The larval aorta and heart were visualized by RFP signal during early pupation. As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As remodeling continued, RFP signal did not return, and no adult heart structures were evident, indicating complete lysis of the heart. Instead, the midline was filled in with rounded fat cells, similar to bic knockdown. Timestamps indicate APFs. Development of the heart may be slowed due to reduced ambient temperatures in the microscope room. See Fig 1 for still images from the video.

    (MP4)

    S3 Video. In vivo imaging of cardiac remodeling during pupation in bic knockdown flies.

    RFP driven by a heart-specific enhancer (tdtk) was imaged throughout pupation every 2 mins starting at approximately 6–8 hour APF (After Puparium Formation). The larval aorta and heart were visualized by RFP signal during early pupation. As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As the heart remodeled, RFP signal declined, especially in the larval aorta (anterior segments of the heart tube). As remodeling continued, RFP signal did not return, and no adult heart structures were evident, indicating complete lysis of the heart. Instead, the midline was filled in with rounded fat cells, similar to Nacα knockdown. Timestamps indicate APFs. Development of the heart may be slowed due to reduced ambient temperatures in the microscope room. See Fig 1 for still images from the video.

    (MP4)

    Attachment

    Submitted filename: Schroeder_Naca_PLoSGResponsetoReviewersResub.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS Genetics are provided here courtesy of PLOS

    RESOURCES